RESULT_COUNT: 358,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
FOLD,FOLD:US,BBG000PLF6N0,"Notable Friday Option Activity: LAMR, ATI, FOLD",2017-10-20 21:00:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WNcoRmq5XLo/notable-friday-option-activity-lamr-ati-fold-cm862911,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Lamar Advertising Co Symbol LAMR where a total volume of 2 522 contracts has been traded thus far today a contract volume which is representative of approximately 252
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Inc (FOLD) Chairman & CEO John F Crowley Sold $6.4 million of Shares,2017-10-17 22:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r_h1GGLnE1Q/amicus-therapeutics-inc-fold-chairman-ceo-john-f-crowley-sold-64-million-of-shares-cm861049,Chairman amp CEO of Amicus Therapeutics Inc FOLD John F Crowley sold 449 295 shares of FOLD on 10 16 2017 at an average price of 14 33 a share The total sale was 6 4 million Chairman CEO of Amicus Therapeutics Inc FOLD John F Crowley sold 449 295 shares of FOLD on 10 16 2017
FOLD,FOLD:US,BBG000PLF6N0,"These Biotech Stocks Are Pricey, but Investors Can Still Buy Them",2017-10-11 01:00:00 +0000,https://finance.yahoo.com/news/biotech-stocks-pricey-investors-still-010000720.html?.tsrc=rss,"Sarepta Therapeutics and Amicus Therapeutics are tackling the unmet need for new treatments for rare conditions, and that could put them in position to generate market-beating returns."
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics Appoints Michael C. Diem, MD as Senior Vice President of Business and Corporate Development",2017-10-06 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-appoints-michael-c-113000623.html?.tsrc=rss,"CRANBURY, N.J., Oct. 06, 2017-- Amicus Therapeutics today announced the appointment of Michael C. Diem, MD as Senior Vice President of Business and Corporate Development. He will be responsible for leading ..."
FOLD,FOLD:US,BBG000PLF6N0,Harry Boxer’s four stocks that are breaking out this week,2017-10-05 15:10:51 +0000,http://finance.yahoo.com/r/52f92a9e-d82d-39c7-838c-9b6fcc9b9b1c/Story.aspx?guid=BB833728-A9DD-11E7-8995-74CFAAC0F219&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"In focus: Amicus Therapeutics, AVEO Pharmaceuticals, AXT and Dynavax Technologies."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics (FOLD) Soars: Stock Adds 9.2% in Session,2017-10-05 12:51:12 +0000,https://finance.yahoo.com/news/amicus-therapeutics-fold-soars-stock-125112562.html?.tsrc=rss,"Amicus Therapeutics (FOLD) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes."
FOLD,FOLD:US,BBG000PLF6N0,Today's Research Reports on Stocks to Watch: Amicus Therapeutics and CytomX Therapeutics,2017-10-05 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000144.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 5, 2017 / Amicus Therapeutics and CytomX Therapeutics both hit new highs on Wednesday. CytomX announced a partnership with Amgen to develop an immuno-oncology drug that ..."
FOLD,FOLD:US,BBG000PLF6N0,Why These Biotechs Are Leading The Group Near A 21-Month High,2017-10-04 20:43:47 +0000,http://finance.yahoo.com/r/cc618335-cdcd-3443-8e65-2dd940e1ab7c/why-these-biotechs-are-leading-the-group-near-a-21-month-high?src=A00220&yptr=yahoo&.tsrc=rss,"Biotech stocks narrowed in on a 21-month high Wednesday with big rises coming from the likes of Intercept, Amicus and Exelixis on positive drug and partnership news."
FOLD,FOLD:US,BBG000PLF6N0,"Wednesday's ETF Movers: IHE, XOP",2017-10-04 19:31:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmHXjaQzFgM/wednesdays-etf-movers-ihe-xop-cm855385,In trading on Wednesday the iShares U S Pharmaceuticals ETF IHE is outperforming other ETFs up about 1 5 on the day Components of that ETF showing particular strength include shares of Mylan MYL up about 18 8 and shares of Amicus Therapeutics FOLD up about 7 6 on the
FOLD,FOLD:US,BBG000PLF6N0,Evidence of Biotech Froth Continues to Mount,2017-10-04 16:38:19 +0000,http://finance.yahoo.com/r/30593850-4eac-3b46-8a70-7470518ce297/biotech-stocks-evidence-of-froth-mounts?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Investors keep driving up shares based on shaky trial data.
FOLD,FOLD:US,BBG000PLF6N0,There's Good Cause To Be Excited About Amicus Therapeutics Clinical Program,2017-10-04 13:59:24 +0000,https://finance.yahoo.com/news/theres-good-cause-excited-amicus-135924904.html?.tsrc=rss,"Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD ) were trading higher by more than 12 percent Wednesday after the company released encouraging clinical trial data. The company's therapy showed a greater ..."
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Oct 4, 2017 :  TEVA, MYL, CATB, AEG, ECYT, FOLD, SAN, QQQ, F, MNKD, BBVA, NVS",2017-10-04 12:59:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mzO5iVVGQjA/pre-market-most-active-for-oct-4-2017-teva-myl-catb-aeg-ecyt-fold-san-qqq-f-mnkd-bbva-nvs-cm855030,The NASDAQ 100 Pre Market Indicator is down 4 47 to 5 990 59 The total Pre Market volume is currently 8 154 709 shares traded The following are the most active stocks for the pre market session Teva Pharmaceutical Industries Limited TEVA is 2 56 at 16 26
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at World Muscle Society,2017-10-04 10:00:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-additional-positive-100000023.html?.tsrc=rss,Mean Six-Minute Walk Distance Improved in ERT-Naive Patients and ERT-Switch Patients. Persistent & Durable Reductions in Key Disease Biomarkers. Pulmonary Function Generally Improved or Remained Stable ...
FOLD,FOLD:US,BBG000PLF6N0,Weekly CEO Buys Highlights,2017-10-02 16:08:36 +0000,https://finance.yahoo.com/news/weekly-ceo-buys-highlights-160836703.html?.tsrc=rss,Insiders invest in RH and Amicus Therapeutics
FOLD,FOLD:US,BBG000PLF6N0,November 10th Options Now Available For Amicus Therapeutics (FOLD),2017-10-02 15:46:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tA7T0w8lDmI/november-10th-options-now-available-for-amicus-therapeutics-fold-cm853875,Investors in Amicus Therapeutics Inc Symbol FOLD saw new options become available today for the November 10th expiration At Stock Options Channel our YieldBoost formula has looked up and down the FOLD options chain for the new November 10th contracts and identified one put and one
FOLD,FOLD:US,BBG000PLF6N0,"Notable Wednesday Option Activity: FOLD, RLGY, CTAS",2017-09-27 20:41:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fMv958QKeOI/notable-wednesday-option-activity-fold-rlgy-ctas-cm852124,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Amicus Therapeutics Inc Symbol FOLD where a total of 20 416 contracts have traded so far representing approximately 2 0 million underlying shares That amounts to about 49 7
FOLD,FOLD:US,BBG000PLF6N0,Today's Research Reports on Trending Tickers: Amicus Therapeutics and Opko Health,2017-09-21 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000799.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 21, 2017 / U.S. markets closed at another record high on Wednesday as bank stocks surged after the Federal Reserve announcement kept the possibility of a December ..."
FOLD,FOLD:US,BBG000PLF6N0,U.S. FDA Grants Orphan Drug Designation for ATB200/AT2221 for Pompe Disease,2017-09-21 11:30:00 +0000,https://finance.yahoo.com/news/u-fda-grants-orphan-drug-113000427.html?.tsrc=rss,"CRANBURY, N.J., Sept. 21, 2017-- Amicus Therapeutics today announced the U.S. FDA has granted orphan drug designation to ATB200/AT2221 for the treatment of Pompe disease, an inherited lysosomal storage ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology,2017-09-20 20:01:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-present-leerink-partners-200100758.html?.tsrc=rss,"CRANBURY, N.J., Sept. 20, 2017-- Amicus Therapeutics announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a corporate overview and fireside chat at the LEERINK Partners ..."
FOLD,FOLD:US,BBG000PLF6N0,Harry Boxer’s five stocks to watch today,2017-09-20 15:26:31 +0000,http://finance.yahoo.com/r/590c90d6-c948-3f91-ad1f-45cbe4cf9290/Story.aspx?guid=BCD28774-9E15-11E7-8DA8-70A592F3D9E7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"In focus: technology, biotechnology and digital advertising."
FOLD,FOLD:US,BBG000PLF6N0,U.S. FDA Grants Fast Track Designation for Amicus Therapeutics’ Migalastat for Treatment of Fabry Disease,2017-09-19 11:30:00 +0000,https://finance.yahoo.com/news/u-fda-grants-fast-track-113000651.html?.tsrc=rss,"CRANBURY, N.J., Sept. 19, 2017-- Amicus Therapeutics announced that the U.S. Food and Drug Administration has granted Fast Track designation for the oral precision medicine migalastat for the treatment ..."
FOLD,FOLD:US,BBG000PLF6N0,"[$$] Clinical Development News, Sept. 11-15",2017-09-18 06:04:37 +0000,http://finance.yahoo.com/r/0ed5ebac-c57a-39ee-9752-eeefdc74bb88/clinical-development-news-sept-11-15-1505714672?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The following is a list of clinical development news from private and public companies during the week of Sept. 11-15.
FOLD,FOLD:US,BBG000PLF6N0,"After Hours Most Active for Sep 15, 2017 :  CDNS, GE, ILG, CHK, CPE, BAC, WFC, QQQ, T, AAPL, MU, FOLD",2017-09-15 21:05:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FCVvB3kMYpk/after-hours-most-active-for-sep-15-2017-cdns-ge-ilg-chk-cpe-bac-wfc-qqq-t-aapl-mu-fold-cm846575,The NASDAQ 100 After Hours Indicator is up 1 31 to 5 989 31 The total After hours volume is currently 241 213 032 shares traded The following are the most active stocks for the after hours session Cadence Design Systems Inc CDNS is unchanged at 38 27 with 30 703
FOLD,FOLD:US,BBG000PLF6N0,Corporate News Blog - Amicus Therapeutics Reports Phase-3 Results for Sd-101 in Epidermolysis Bullosa did not Meet Primary Endpoints,2017-09-15 11:40:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-amicus-therapeutics-114000871.html?.tsrc=rss,"Research Desk Line-up: Cellect Biotech Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 15, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Approval for Galafold™ (Migalastat) for Treatment of Fabry Disease in Canada,2017-09-14 20:01:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-approval-galafold-200100591.html?.tsrc=rss,"CRANBURY, N.J., Sept. 14, 2017-- Amicus Therapeutics announced that Health Canada has approved the oral precision medicine Galafold for long-term treatment of adults with a confirmed diagnosis of Fabry ..."
FOLD,FOLD:US,BBG000PLF6N0,"FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot",2017-09-14 03:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09APhjRftng/fda-panel-nod-for-gsks-shingles-vaccine-fold-beyond-essence-fenc-is-red-hot-20170914-00117,"FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus abandons wound treatment, focus shifts to future trial data",2017-09-13 15:35:35 +0000,https://finance.yahoo.com/news/amicus-abandon-wound-treatment-fails-104722596.html?.tsrc=rss,"Amicus Therapeutics Inc said on  Wednesday it would stop developing its experimental drug for  healing wounds related to a rare skin disease, but shares of the  company rose as investors appeared to focus on the drug  developer's expanding pipeline.  Amicus's shares rose as much as 6 percent in morning  trading, recovering from a nearly 15 percent slide before the  bell."
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Sep 13, 2017 :  AGNC, WDAY, FOLD, MU, AAPL, TEVA, AZN, TVIX, SKM, BCRX, BAC, JWN",2017-09-13 12:54:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CDTq6EOPX_o/pre-market-most-active-for-sep-13-2017-agnc-wday-fold-mu-aapl-teva-azn-tvix-skm-bcrx-bac-jwn-cm844799,The NASDAQ 100 Pre Market Indicator is down 5 72 to 5 989 92 The total Pre Market volume is currently 6 359 847 shares traded The following are the most active stocks for the pre market session AGNC Investment Corp AGNC is 0 65 at 20 85 with 6 377 490 shares
FOLD,FOLD:US,BBG000PLF6N0,A father's fight to find a cure for his children's rare disease,2017-09-13 12:32:42 +0000,https://finance.yahoo.com/video/fathers-fight-cure-childrens-rare-123242167.html?.tsrc=rss,"Amicus Therapeutics CEO John Crowley on how his fight to find a cure for his children's rare disease, Pompe, has driven his work in the pharmaceutical industry."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics' wound treatment fails late-stage trial,2017-09-13 10:21:57 +0000,https://finance.yahoo.com/news/amicus-therapeutics-wound-treatment-fails-102157192.html?.tsrc=rss,"U.S. drug developer Amicus Therapeutics Inc said on Wednesday its drug to treat wounds failed to meet the main goals of a late-stage clinical trial. The company said its drug, when compared with a placebo, ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Top-Line Phase 3 Results for SD-101 in Epidermolysis Bullosa,2017-09-13 10:00:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-top-line-100000634.html?.tsrc=rss,"Study Did Not Meet Primary Endpoints. Conference Call and Webcast Today at 8:30am ET. CRANBURY, N.J., Sept. 13, 2017-- Amicus Therapeutics, Inc. reported that top-line data from the randomized, double-blind, ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus: Phase 3 SD-101 Study Fails To Meet Primary Endpoints - Quick Facts,2017-09-13 06:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ufPHdh9Yqic/amicus-phase-3-sd101-study-fails-to-meet-primary-endpoints--quick-facts-20170913-00204,Amicus: Phase 3 SD-101 Study Fails To Meet Primary Endpoints - Quick Facts
FOLD,FOLD:US,BBG000PLF6N0,Options Traders Expect Huge Moves in Amicus Therapeutics (FOLD) Stock,2017-09-12 14:39:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dQnuxW1B78s/options-traders-expect-huge-moves-in-amicus-therapeutics-fold-stock-cm844239,Investors in Amicus Therapeutics Inc FOLD need to pay close attention to the stock based on moves in the options market lately That is because the Sep 15 2017 10 Put had some of the highest implied volatility of all equity options today What is Implied Volatility Implied
FOLD,FOLD:US,BBG000PLF6N0,Options Traders Expect Huge Moves in Amicus Therapeutics (FOLD) Stock,2017-09-12 12:56:12 +0000,https://finance.yahoo.com/news/options-traders-expect-huge-moves-125612686.html?.tsrc=rss,Amicus Therapeutics (FOLD) needs Investors to pay close attention to the stock based on moves in the options market lately.
FOLD,FOLD:US,BBG000PLF6N0,Is Amicus Therapeutics Stock Still a Strong Buy?,2017-09-10 13:49:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Wh-i3_GE5k/is-amicus-therapeutics-stock-still-a-strong-buy-cm843384,What happened According to data from S amp P Global Market Intelligence shares of rare disease drugmaker Amicus Therapeutics NASDAQ FOLD rose by 6 6 last month Although the company did provide a bevy of clinical and business updates during its second quarter earnings
FOLD,FOLD:US,BBG000PLF6N0,Is Amicus Therapeutics Stock Still a Strong Buy?,2017-09-10 12:31:00 +0000,http://finance.yahoo.com/r/7bf492fa-529c-31f5-bc01-abb8f3c25a3a/is-amicus-therapeutics-stock-still-a-strong-buy.aspx?yptr=yahoo&.tsrc=rss,Amicus&apos; stock continues to benefit from its emerging rare disease pipeline and the industrywide upswing in biotech valuations this year.
FOLD,FOLD:US,BBG000PLF6N0,Time to Bring Amicus Therapeutics Into the 'FOLD',2017-09-08 14:09:00 +0000,http://finance.yahoo.com/r/3e790f17-b11c-38d3-8051-f38b5ac47fe6/time-bring-amicus-therapeutics-fold?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Shares of this biotech look ready for further strong gains.
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Highlight Fabry Disease Program at the 13th International Congress of Inborn Errors of Metabolism (ICIEM),2017-08-25 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-highlight-fabry-disease-113000621.html?.tsrc=rss,"CRANBURY, N.J., Aug. 25, 2017-- Amicus Therapeutics, today announced that 6 posters highlighting its Fabry program will be included in the 13 th International Congress of Inborn Errors of Metabolism to ..."
FOLD,FOLD:US,BBG000PLF6N0,Today's Research Reports on Stocks to Watch: Amicus Therapeutics Inc. and Ritter Pharmaceuticals Inc.,2017-08-21 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000795.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 21, 2017 / Geopolitical concerns combined with the resignation of multiple advisors to President Trump pressured markets lower last week. On Friday, the Dow Jones Industrial ..."
FOLD,FOLD:US,BBG000PLF6N0,"[$$] Clinical Development News, Aug. 14-18",2017-08-21 01:17:04 +0000,http://finance.yahoo.com/r/a713c9a8-367a-33e6-a8fb-6135b3c0eca3/clinical-development-news-aug-14-18-1503278220?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The following is a list of clinical development news from private and public companies during the week of Aug. 14-18.
FOLD,FOLD:US,BBG000PLF6N0,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges",2017-08-16 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPeOCxT4xeY/alxns-strengthening-patents-folds-fabry-drug-approved-in-oz-vbiv-surges-20170816-00044,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Approval for Galafold™ (Migalastat) for Treatment of Fabry Disease in Australia,2017-08-15 20:01:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-approval-galafold-200100999.html?.tsrc=rss,"First Amicus Medicine and First Oral Precision Medicine for Fabry Disease in Australia. Broad Label for Fabry Patients with an Amenable Genetic Mutation. CRANBURY, N.J., Aug. 15, 2017-- Amicus Therapeutics ..."
FOLD,FOLD:US,BBG000PLF6N0,Edited Transcript of FOLD earnings conference call or presentation 7-Aug-17 12:30pm GMT,2017-08-12 10:01:23 +0000,https://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-172035939.html?.tsrc=rss,Q2 2017 Amicus Therapeutics Inc Earnings Call
FOLD,FOLD:US,BBG000PLF6N0,"The Sole Reason Amicus Therapeutics, Inc. Exploded 29% Higher in July",2017-08-09 20:37:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q9GLv8auYqY/the-sole-reason-amicus-therapeutics-inc-exploded-29-higher-in-july-cm829770,What happened Shares of Amicus Therapeutics NASDAQ FOLD a biopharmaceutical company focused on the development rare disease drugs exploded higher by 29 during the month of July according to data from S amp P Global Market Intelligence The culprit for the decisive
FOLD,FOLD:US,BBG000PLF6N0,"The Sole Reason Amicus Therapeutics, Inc. Exploded 29% Higher in July",2017-08-09 19:07:00 +0000,http://finance.yahoo.com/r/ec80292a-5283-3c34-a924-83857025d20c/the-sole-reason-amicus-therapeutics-inc-exploded-2.aspx?yptr=yahoo&.tsrc=rss,"The Food and Drug Administration changed its tune on Amicus&apos; lead drug, and shareholders couldn&apos;t be happier."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 2Q loss,2017-08-08 03:57:45 +0000,https://finance.yahoo.com/news/amicus-therapeutics-reports-2q-loss-112100630.html?.tsrc=rss,"The Cranbury, New Jersey-based company said it had a loss of 34 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Second Quarter 2017 Financial Results and Corporate Updates,2017-08-07 11:00:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-second-quarter-110000450.html?.tsrc=rss,179 Fabry Disease Patients on Reimbursed Galafold as of July 31– On Target to Reach 300 Patients by Year-End 2017. Migalastat NDA Submission Targeted for 4 Q17. Phase 3 EB Topline Data and Complete Phase ...
FOLD,FOLD:US,BBG000PLF6N0,"Investor Network: Amicus Therapeutics, Inc. to Host Earnings Call",2017-08-07 10:10:00 +0000,https://finance.yahoo.com/news/investor-network-amicus-therapeutics-inc-101000917.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 7, 2017 / Amicus Therapeutics, Inc. (NASDAQ: FOLD) will be discussing their earnings results in their Q2 Earnings Call to be held on Monday, August 07, 2017 at 8:30 AM ..."
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Earnings Report for August 7, 2017 :  TSN, FDC, ON, BAH, DCP, GEO, KOS, IIVI, HAE, FOLD, HZNP, FI",2017-08-04 20:18:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aj-Wgxxp6IA/pre-market-earnings-report-for-august-7-2017-tsn-fdc-on-bah-dcp-geo-kos-iivi-hae-fold-hznp-fi-cm827533,The following companies are expected to report earnings prior to market open on 08 07 2017 Visit our Earnings Calendar for a full list of expected earnings releases Tyson Foods Inc TSN is reporting for the quarter ending June 30 2017 The meat
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Aug 2, 2017 :  ING, AAPL, INVA, FOLD, PMC, BTI, QQQ, AZN, USLV, QUOT, AMC, MU",2017-08-02 12:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-vw0G2Vuu_4/pre-market-most-active-for-aug-2-2017-ing-aapl-inva-fold-pmc-bti-qqq-azn-uslv-quot-amc-mu-cm825486,The NASDAQ 100 Pre Market Indicator is up 55 57 to 5 950 74 The total Pre Market volume is currently 7 318 745 shares traded The following are the most active stocks for the pre market session ING Group N V ING is 0 26 at 18 61 with 2 946 164 shares traded
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce Second Quarter 2017 Financial Results on August 7, 2017",2017-07-25 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announce-second-quarter-113000341.html?.tsrc=rss,"CRANBURY, N.J., July 25, 2017-- Amicus Therapeutics today announced a conference call and live audio webcast on August 7, 2017 at 8:30 a.m. ET to discuss financial results for the second quarter ended ..."
FOLD,FOLD:US,BBG000PLF6N0,Company Spotlight: Amicus,2017-07-21 07:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K5LICwUKAi4/company-spotlight-amicus-20170721-00278,Company Spotlight: Amicus
FOLD,FOLD:US,BBG000PLF6N0,4 Momentum Plays To Watch,2017-07-19 16:54:00 +0000,http://finance.yahoo.com/r/65172d80-c9b8-3519-ae57-4b01d797b84e/4-momentum-plays-to-watch?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Momentum stocks continue to run on strong technicals and favorable news. Here are four to keep an eye on.
FOLD,FOLD:US,BBG000PLF6N0,4 Momentum Plays to Watch,2017-07-19 15:26:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upoNG8jdWTo/4-momentum-plays-to-watch-cm818151,"By Harry Boxer   Momentum stocks we follow continue to run on strong technicals and favorable news.  Here are four more to watch.  Amicus Therapeutics, Inc. ( FOLD )  rocketed up 90 cents, or nearly 7%, to close at $13.81 on unusually heavy volume of 7.8 million shares traded Tuesday. The move came with news that"
FOLD,FOLD:US,BBG000PLF6N0,5 Hot Insider Stock Picks You Need to Know,2017-07-19 00:02:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EonQLA5BwGM/5-hot-insider-stock-picks-you-need-to-know-cm817823,InvestorPlace Stock Market News Stock Advice amp Trading Tips Which are the five hottest insider trading stocks right now Using TipRanks Insider Hot Stocks tool we split the transactions into informative and uninformative insider transactions so that we can find the best
FOLD,FOLD:US,BBG000PLF6N0,"Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH...",2017-07-18 22:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/87QxJ7oXNTk/gainers--losers-of-july-18-capr-nvax-ttoo-imuc-sbph-20170718-01422,"Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares,2017-07-18 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-closing-underwritten-113000110.html?.tsrc=rss,"CRANBURY, N.J., July 18, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced the closing of its previously announced offering ..."
FOLD,FOLD:US,BBG000PLF6N0,No Surprise! Amicus Therapeutics Hits Up Investors for More Cash,2017-07-14 02:47:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sa8dx1QzDSY/no-surprise-amicus-therapeutics-hits-up-investors-for-more-cash-cm815948,Amicus Therapeutics NASDAQ FOLD 160 will be able to submit its 160 Fabry disease drug Galafold to the FDA for consideration a reversal of fortune that sent shares skyrocketing earlier this week While news of the FDA s change of heart was unexpected management s decision
FOLD,FOLD:US,BBG000PLF6N0,No Surprise! Amicus Therapeutics Hits Up Investors for More Cash,2017-07-14 01:01:00 +0000,http://finance.yahoo.com/r/f55244d2-e7d2-3b6c-b811-3608958aac81/no-surprise-amicus-therapeutics-hits-up-investors.aspx?yptr=yahoo&.tsrc=rss,"After an about-face at the FDA sent shares soaring earlier this week, management announced a stock offering to bolster its balance sheet."
FOLD,FOLD:US,BBG000PLF6N0,Mid-Morning Market Update: Markets Edge Higher; Delta Air Lines Profit Misses Expectations,2017-07-13 17:15:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DbkynURJD0E/mid-morning-market-update-markets-edge-higher-delta-air-lines-profit-misses-expectations-cm815756,Following the market opening Thursday the Dow traded up 0 02 percent to 21 536 92 while the NASDAQ climbed 0 20 percent to 6 273 68 The S amp P also rose gaining 0 11 percent to 2 445 84 Leading and Lagging Sectors Technology shares rose by 1 percent in the US market on
FOLD,FOLD:US,BBG000PLF6N0,Mid-Day Market Update: Yandex Jumps Following Announcement Of Deal With Uber; Amicus Therapeutics Shares Drop,2017-07-13 17:15:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ROhMGRDeevc/mid-day-market-update-yandex-jumps-following-announcement-of-deal-with-uber-amicus-therapeutics-shares-drop-cm815755,Midway through trading Thursday the Dow traded up 0 13 percent to 21 559 20 while the NASDAQ climbed 0 09 percent to 6 266 56 The S amp P also rose gaining 0 18 percent to 2 447 62 Leading and Lagging Sectors Technology shares rose by 1 percent in the US market on Thursday
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Pulling Back After Offering Announcement,2017-07-13 14:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/99dsG5tFlNQ/amicus-therapeutics-pulling-back-after-offering-announcement-20170713-01000,Amicus Therapeutics Pulling Back After Offering Announcement
FOLD,FOLD:US,BBG000PLF6N0,This $3 Biotech Stock Is Making an 11% Move Thursday,2017-07-13 13:28:00 +0000,http://finance.yahoo.com/r/f6db0be3-ac6f-314c-ae54-cc1bc1d2f2e5/biotech-movers-amicus-arena-trevena.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,In focus.
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Jul 13, 2017 :  YNDX, FOLD, SNAP, MT, ALDR, ARNA, TEF, QAT, DAL, TGT, QQQ, TEVA",2017-07-13 12:54:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xOqWnJJFg5Q/pre-market-most-active-for-jul-13-2017-yndx-fold-snap-mt-aldr-arna-tef-qat-dal-tgt-qqq-teva-cm815385,The NASDAQ 100 Pre Market Indicator is up 6 24 to 5 785 19 The total Pre Market volume is currently 4 422 128 shares traded The following are the most active stocks for the pre market session Yandex N V YNDX is 5 18 at 32 51 with 2 639 346 shares traded As
FOLD,FOLD:US,BBG000PLF6N0,Stocks Nearly Flat After Seeing Initial Strength - U.S. Commentary,2017-07-13 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xkYdtxYegQM/stocks-nearly-flat-after-seeing-initial-strength--us-commentary-20170713-00811,Stocks Nearly Flat After Seeing Initial Strength - U.S. Commentary
FOLD,FOLD:US,BBG000PLF6N0,Stocks Nearly Flat After Seeing Initial Strength - U.S. Commentary,2017-07-13 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wgP_h5b7CcA/stocks-nearly-flat-after-seeing-initial-strength--u.s.-commentary-20170713-00811,Stocks Nearly Flat After Seeing Initial Strength - U.S. Commentary
FOLD,FOLD:US,BBG000PLF6N0,InPlay from Briefing.com,2017-07-13 07:56:15 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
FOLD,FOLD:US,BBG000PLF6N0,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track",2017-07-13 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hzBiyLUIVzY/nvs-gets-thumbs-up-two-biosimilar-candidates-to-face-fda-panel-vktx-on-track-20170713-00059,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Public Offering of Common Stock,2017-07-12 20:01:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-public-offering-200100511.html?.tsrc=rss,"CRANBURY, N.J., July 12, 2017-- Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced it has commenced a $225 million underwritten ..."
FOLD,FOLD:US,BBG000PLF6N0,4 Momentum Stocks to Watch,2017-07-12 16:57:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BkgWTDZMTTI/4-momentum-stocks-to-watch-cm815189,"By Harry Boxer   Strong technical momentum and positive news are powering some of the stocks we follow.  Here are four to watch.  Amicus Therapeutics, Inc. ( FOLD ) performed phenomenally on Tuesday, popping $2.66, or 26%, to $12.92, on 24 million shares traded. The move followed positive FDA submission news for the"
FOLD,FOLD:US,BBG000PLF6N0,"Company News for July 12, 2017",2017-07-12 16:48:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VvkRWYmALZc/company-news-for-july-12-2017-cm815127,160 160 160 Shares of Amicus Therapeutics Inc FOLD soared 25 9 following news that the company has received permission from the U S Food and Drug Administration to submit an experimental drug for approval 160 160 160 Simulations Plus Inc s SLP shares gained 6 2
FOLD,FOLD:US,BBG000PLF6N0,"Company News for July 12, 2017",2017-07-12 14:25:02 +0000,https://finance.yahoo.com/news/company-news-july-12-2017-142502507.html?.tsrc=rss,"Companies in the News are: FOLD,SLP,ARNA,EVGN,MON"
FOLD,FOLD:US,BBG000PLF6N0,"Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal",2017-07-12 13:39:01 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-arena-shoots-133901394.html?.tsrc=rss,Arena (ARNA) saw it shares shoot up on mid-stage data on its pulmonary arterial hypertension drug while quite a few companies provided regulatory updates.
FOLD,FOLD:US,BBG000PLF6N0,"Today's Research Reports on Stocks to Watch: Amicus Therapeutics, Inc. and NovoCure Ltd.",2017-07-12 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000334.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 12, 2017 / Shares of NovoCure saw a big leap on Tuesday as investors wait for the company's update on its Optune device this week. Traders are also patiently waiting for ..."
FOLD,FOLD:US,BBG000PLF6N0,One FDA About-Face Doesn't Mean an Orphan-Drug Bonanza,2017-07-12 11:30:10 +0000,http://finance.yahoo.com/r/0798ba09-f49d-37c8-a214-8da74735898c/amicus-fda-reversal-doesn-t-signal-orphan-drug-bonanza?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&trackingId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Even if its Amicus reversal isn't a one-off, don't expect a flood of pricey new drugs."
FOLD,FOLD:US,BBG000PLF6N0,[$$] Amicus Therapeutics Gets Nod From FDA to Submit Experimental Drug for Approval,2017-07-12 04:40:26 +0000,http://finance.yahoo.com/r/8daa4e04-6008-333b-afb6-28ee0eec4fbf/amicus-therapeutics-gets-nod-from-fda-to-submit-experimental-drug-for-approval-1499809341?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,A biotechnology company said the U.S. Food and Drug Administration allowed it to submit an experimental drug for approval without running an additional clinical study that the agency previously demanded....
FOLD,FOLD:US,BBG000PLF6N0,Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run,2017-07-12 00:39:00 +0000,http://finance.yahoo.com/r/ff97a594-050a-3fd5-a974-571fbfadcc77/arena-shares-skyrocket-on-positive-data-for-ralinepag.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Big gains could be ahead for investors willing to stick with the stock, according to one firm."
FOLD,FOLD:US,BBG000PLF6N0,How Big Is Amicus Therapeutics Galafold Opportunity in The U.S.?,2017-07-11 23:45:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4es7Wfzg6Yc/how-big-is-amicus-therapeutics-galafold-opportunity-in-the-us-cm814786,The FDA previously told Amicus Therapeutics NASDAQ FOLD 160 it would need to conduct another study of its Fabry disease drug Galafold before regulators would consider approving it Now however the agency has opened the door for an approval without that study and that
FOLD,FOLD:US,BBG000PLF6N0,How Big Is Amicus Therapeutics Galafold Opportunity in The U.S.?,2017-07-11 22:01:00 +0000,http://finance.yahoo.com/r/5678ed9c-381f-3a7e-a39c-624aeecbd3d4/how-big-is-amicus-therapeutics-galafold-opportunit.aspx?yptr=yahoo&.tsrc=rss,"Regulators in the U.S. are reversing their prior view on Galafold, and Amicus Therapeutics plans to file for FDA approval this year."
FOLD,FOLD:US,BBG000PLF6N0,"Why Halcon Resources, Amicus Therapeutics, and Rent-A-Center Jumped Today",2017-07-11 21:46:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BMCd7OeCv80/why-halcon-resources-amicus-therapeutics-and-rent-a-center-jumped-today-cm814716,Tuesday was another lackluster day on Wall Street and major benchmarks didn t move much as market participants largely fell prey to the summer doldrums Some traders focused on the release of email communications by President Trump s oldest son as a worrisome sign of potential
FOLD,FOLD:US,BBG000PLF6N0,"Why Amicus Therapeutics, Inc. (FOLD) Stock Is Soaring Today",2017-07-11 21:44:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3BpDg-tPDkI/why-amicus-therapeutics-inc-fold-stock-is-soaring-today-cm814752,InvestorPlace Stock Market News Stock Advice amp Trading Tips Amicus Therapeutics Inc NASDAQ FOLD stock was flying high today on positive news from the 160 U S Food and Drug Administration FDA Source Shutterstock Amicus Therapeutics Inc says that the FDA
FOLD,FOLD:US,BBG000PLF6N0,"Gainers & Losers Of July 11: ARNA, FOLD, VSTM, TOCA, GTHX...",2017-07-11 21:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sQ-n2SVURQs/gainers--losers-of-july-11-arna-fold-vstm-toca-gthx-20170711-01353,"Gainers & Losers Of July 11: ARNA, FOLD, VSTM, TOCA, GTHX..."
FOLD,FOLD:US,BBG000PLF6N0,These Small Biotechs Are Leading The Pack Today — Here&apos;s Why,2017-07-11 20:57:01 +0000,http://finance.yahoo.com/r/4bdb92d3-7558-3ba3-9105-d6abb276f68f/these-small-biotechs-are-leading-the-pack-today-heres-why?src=A00220&yptr=yahoo&.tsrc=rss,"Arena and Amicus stocks led the biotech pack Tuesday on strong Phase 2 drug data and a favorable regulatory decision, respectively."
FOLD,FOLD:US,BBG000PLF6N0,"Why Halcon Resources, Amicus Therapeutics, and Rent-A-Center Jumped Today",2017-07-11 20:35:00 +0000,http://finance.yahoo.com/r/53df5e3d-a1b8-36ee-a7db-661b8ab8262c/why-halcon-resources-amicus-therapeutics-and-rent.aspx?yptr=yahoo&.tsrc=rss,These stocks were big winners on a flat day on Wall Street. Find out why.
FOLD,FOLD:US,BBG000PLF6N0,Mid-Afternoon Market Update: Crude Oil Up 1.5%; VOXX International Shares Plummet,2017-07-11 19:39:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UaH2UWHuZPI/mid-afternoon-market-update-crude-oil-up-15-voxx-international-shares-plummet-cm814669,Toward the end of trading Tuesday the Dow traded up 0 09 percent to 21 428 25 while the NASDAQ climbed 0 23 percent to 6 190 72 However the S amp P dropped 0 04 percent to 2 426 59 Leading and Lagging Sectors Technology shares rose by 0 8 percent in the US market on Tuesday
FOLD,FOLD:US,BBG000PLF6N0,"Health Care Sector Update for 07/11/2017: FOLD,ARNA,NEOT",2017-07-11 18:04:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_MvU7wszqZ4/health-care-sector-update-for-07112017-foldarnaneot-cm814610,Top Health Care StocksTop Health Care Stocks JNJ 0 19 JNJ 0 19 PFE 0 40 PFE 0 40 ABT 0 08 ABT 0 08 MRK 0 35 MRK 0 35 AMGN 0 62 AMGN 0 62 Health care stocks still were underwater this afternoon with the NYSE Health Care Index declining about 0 1 while shares of health care
FOLD,FOLD:US,BBG000PLF6N0,"Why Amicus Therapeutics, Inc. (FOLD) Stock Is Soaring Today",2017-07-11 17:13:28 +0000,https://finance.yahoo.com/news/why-amicus-therapeutics-inc-fold-171328294.html?.tsrc=rss,"Amicus Therapeutics, Inc. says that the FDA is allowing it to submit a new drug application for migalastat.  This is the company’s oral precision medicine to treat Fabry disease. FOLD stock is on the rise after the company said it will submit this new drug application in the fourth quarter of 2017."
FOLD,FOLD:US,BBG000PLF6N0,Mid-Day Market Update: Halcon Resources Jumps After Announcing Sale of Williston Basin Assets; Shiloh Industries Shares Slide,2017-07-11 17:09:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Il0v_qxu1B8/mid-day-market-update-halcon-resources-jumps-after-announcing-sale-of-williston-basin-assets-shiloh-industries-shares-slide-cm814585,Midway through trading Tuesday the Dow traded up 0 10 percent to 21 429 54 while the NASDAQ climbed 0 29 percent to 6 194 43 The S amp P also rose gaining 0 01 percent to 2 427 46 Leading and Lagging Sectors Technology shares rose by 0 5 percent in the US market on Tuesday
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Inc. Rocketed Higher Today,2017-07-11 16:53:00 +0000,http://finance.yahoo.com/r/64caf5a5-784c-39d3-a0da-e360ac6a6629/why-amicus-therapeutics-inc-rocketed-higher-today.aspx?yptr=yahoo&.tsrc=rss,The FDA reversed itself and agreed to accept the biotech&apos;s current data as a basis for considering approval of Fabry disease treatment migalastat.
FOLD,FOLD:US,BBG000PLF6N0,Story Stocks from Briefing.com,2017-07-11 16:51:57 +0000,https://finance.yahoo.com/news/story-stocks-briefing-com-175403381.html?.tsrc=rss,Story Stocks from Briefing.com
FOLD,FOLD:US,BBG000PLF6N0,Amicus jumps 28 percent after FDA speeds approval process...,2017-07-11 15:44:00 +0000,https://finance.yahoo.com/video/amicus-jumps-28-percent-fda-154400172.html?.tsrc=rss,CNBC's Meg Tirrell reports on the Food and Drug Administration's reversal on a ruling to run an additional late clinical stage study for a rare disease drug.
FOLD,FOLD:US,BBG000PLF6N0,Mid-Morning Market Update: Markets Mostly Flat; PepsiCo Profit Tops Expectations,2017-07-11 15:39:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lUit_Om1E8k/mid-morning-market-update-markets-mostly-flat-pepsico-profit-tops-expectations-cm814479,Following the market opening Tuesday the Dow traded down 0 04 percent to 21 400 58 while the NASDAQ climbed 0 07 percent to 6 180 49 The S amp P also fell dropping 0 1 percent to 2 424 73 Leading and Lagging Sectors Technology shares rose by 0 5 percent in the US market
FOLD,FOLD:US,BBG000PLF6N0,Stock Futures Turn Lower on Oil-Related Sell-Off in Europe,2017-07-11 13:46:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_egZiEZokBs/stock-futures-turn-lower-on-oil-related-sell-off-in-europe-cm814315,U S stock futures were set to open modestly lower on Tuesday in sympathy with an oil related sell off in European equities Oil unraveled early this morning following a forecast from Goldman Sachs for West Texas intermediate to fall under 40 per barrel U S stock futures were set to open
FOLD,FOLD:US,BBG000PLF6N0,"Stocks Open Mixed: This Biotech Soars 42%; Snap, Blue Apron Fold",2017-07-11 13:43:34 +0000,http://finance.yahoo.com/r/810f2cda-b916-3ed4-a333-852893cdd0d1/stock-futures-sag-big-oil-little-pharma-notch-early-gains?src=A00220&yptr=yahoo&.tsrc=rss,Stock futures set up for a slightly weak open on Tuesday as investors looked toward two days of congressional testimony from Fed Chief Janet Yellen starting Wednesday.
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Jul 11, 2017 :  FOLD, HK, SNAP, SHPG, GTY, OCUL, ARNA, RCII, PSO, PEP, WLL, QQQ",2017-07-11 12:54:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YjsvHZsPRtU/pre-market-most-active-for-jul-11-2017-fold-hk-snap-shpg-gty-ocul-arna-rcii-pso-pep-wll-qqq-cm814236,The NASDAQ 100 Pre Market Indicator is down 4 21 to 5 689 94 The total Pre Market volume is currently 3 868 534 shares traded The following are the most active stocks for the pre market session Amicus Therapeutics Inc FOLD is 3 1 at 13 36 with 1 937 962
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics's stock soars on heavy volume after FDA clears NDA submission for Fabry disease treatment,2017-07-11 11:58:32 +0000,http://finance.yahoo.com/r/301746ad-9979-32ab-9c8c-0c967fd6f6c8/Story.aspx?guid=3762EDE2-9A23-45DE-BB49-DF68AA673C5C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Amicus Therapeutics Inc. shot up 40% toward a 22-month high in active premarket trade Tuesday, after the biotechnology company said the Food and Drug Administration cleared the company to submit ..."
FOLD,FOLD:US,BBG000PLF6N0,"FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug",2017-07-11 10:00:00 +0000,http://finance.yahoo.com/r/2a30c737-9ef5-3af3-bc63-140bdb5d1b58/fda-reverses-decision-allowing-amicus-to-file-for-rare-disease-drug?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Last November, tiny Amicus Therapeutics said that the Food and Drug Administration would not consider approving migalastat, a treatment for a rare disorder called Fabry disease. Today, Amicus says that the FDA is reversing the decision, and that there is a clear path to approval."
FOLD,FOLD:US,BBG000PLF6N0,U.S. FDA Confirms Amicus Therapeutics May Submit New Drug Application for Migalastat for Fabry Disease,2017-07-11 10:00:00 +0000,https://finance.yahoo.com/news/u-fda-confirms-amicus-therapeutics-100000893.html?.tsrc=rss,Data Deemed Sufficient to Support NDA Submission. NDA Submission Targeted for 4 Q17. Conference Call Today at 8:30am ET.
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics (FOLD) Has Jumped To A New High On FDA News,2017-07-11 09:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wqMexMRhPuU/amicus-therapeutics-fold-has-jumped-to-a-new-high-on-fda-news-20170711-00709,Amicus Therapeutics (FOLD) Has Jumped To A New High On FDA News
FOLD,FOLD:US,BBG000PLF6N0,Amicus Says FDA Okays NDA Submission For Fabry Disease Treatment; Stock Up,2017-07-11 08:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zNOeEvFzPzE/amicus-says-fda-okays-nda-submission-for-fabry-disease-treatment-stock-up-20170711-00551,Amicus Says FDA Okays NDA Submission For Fabry Disease Treatment; Stock Up
FOLD,FOLD:US,BBG000PLF6N0,Sum Up The Pieces: IHE Could Be Worth $185,2017-07-07 14:44:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HGZP08ahBiA/sum-up-the-pieces-ihe-could-be-worth-185-cm812903,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
FOLD,FOLD:US,BBG000PLF6N0,"Noteworthy Thursday Option Activity: CREE, TWTR, FOLD",2017-07-06 20:44:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-uU37bDAwWI/noteworthy-thursday-option-activity-cree-twtr-fold-cm812671,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Cree Inc Symbol CREE where a total volume of 7 506 contracts has been traded thus far today a contract volume which is representative of approximately 750 600
FOLD,FOLD:US,BBG000PLF6N0,"Commit To Buy Amicus Therapeutics At $8, Earn 27.7% Annualized Using Options",2017-07-05 17:47:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wmVUw0xcAbg/commit-to-buy-amicus-therapeutics-at-8-earn-277-annualized-using-options-cm811967,Investors eyeing a purchase of Amicus Therapeutics Inc Symbol FOLD stock but cautious about paying the going market price of 10 24 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Submits Japanese New Drug Application for Migalastat for Fabry Disease,2017-06-28 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-submits-japanese-drug-113000154.html?.tsrc=rss,"CRANBURY, N.J., June 28, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has submitted a Japanese new drug application to the Pharmaceuticals and ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 7.3%,2017-06-19 12:37:12 +0000,https://finance.yahoo.com/news/amicus-therapeutics-fold-catches-eye-123712011.html?.tsrc=rss,"Amicus Therapeutics, Inc. (FOLD) was a big mover last session, as the company saw its shares rise over 7% on the day."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics: Is This Biotech an Orphan Underdog?,2017-06-14 16:09:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mJt9mO09Mdk/amicus-therapeutics-is-this-biotech-an-orphan-underdog-cm803327,One of the hottest areas to invest in biotech is the orphan sector Orphan diseases as defined by the FDA are medical conditions that affect fewer than 200 000 people within the U S Due to the nature of these underserved indications the FDA has incentivized development of
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics: Is This Biotech an Orphan Underdog?,2017-06-14 14:28:00 +0000,http://finance.yahoo.com/r/b31fb663-6896-3521-b04f-0ebeaa9824c2/amicus-therapeutics-is-this-biotech-an-orphan-unde.aspx?yptr=yahoo&.tsrc=rss,"After months of crazy volatility, the stock seems to have made up its mind on which direction to go: up"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Goldman Sachs 38th Annual Global Healthcare Conference,2017-06-07 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-present-goldman-sachs-113000008.html?.tsrc=rss,"CRANBURY, N.J., June 07, 2017-- Amicus Therapeutics, Inc. announced today that John F. Crowley, Chairman and Chief Executive Officer, will participate in a corporate overview and fireside chat at the upcoming ..."
FOLD,FOLD:US,BBG000PLF6N0,Here's Why Amicus Therapeutics Stock Edged Higher in May,2017-06-06 16:19:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/drVNIrwcUbE/heres-why-amicus-therapeutics-stock-edged-higher-in-may-cm799457,What happened Shares of rare disease drugmaker Amicus Therapeutics NASDAQ FOLD edged higher last month on the back of the company s first quarter earnings release Specifically the biotech s shares gained 2 43 in May according to data from S amp P Global Market
FOLD,FOLD:US,BBG000PLF6N0,Here&apos;s Why Amicus Therapeutics Stock Edged Higher in May,2017-06-06 15:12:00 +0000,http://finance.yahoo.com/r/8d34beaa-d603-3f2e-96b6-b6e155e54255/heres-why-amicus-therapeutics-stock-edged-higher-i.aspx?yptr=yahoo&.tsrc=rss,Evidence of the drugmaker&apos;s continued maturation pushed its shares higher last month.
FOLD,FOLD:US,BBG000PLF6N0,3 Stocks With Vertex Pharmaceuticals-Like Return Potential,2017-06-03 14:31:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ebVQOhrzjrA/3-stocks-with-vertex-pharmaceuticals-like-return-potential-cm798352,Over the past decade Vertex 160 Pharmaceuticals NASDAQ VRTX stock has tripled in value thanks in large part to the success of its core cystic fibrosis drug franchise With this biotech s shares now trading at a sky high forward price to earnings ratio of 41 however it
FOLD,FOLD:US,BBG000PLF6N0,3 Stocks With Vertex Pharmaceuticals-Like Return Potential,2017-06-03 13:01:00 +0000,http://finance.yahoo.com/r/de0cd226-5b5b-3e13-8404-d73d2c84d410/3-stocks-with-vertex-pharmaceuticals-like-return-p.aspx?yptr=yahoo&.tsrc=rss,These three biotechs may be ready for a Vertex-like run higher.
FOLD,FOLD:US,BBG000PLF6N0,"After Hours Most Active for Jun 1, 2017 :  JCP, TGNA, INFO, HOMB, TIME, CARS, MTDR, WNR, INTC, LULU, CTXS, FOLD",2017-06-01 21:01:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zKRpxy6YqNk/after-hours-most-active-for-jun-1-2017-jcp-tgna-info-homb-time-cars-mtdr-wnr-intc-lulu-ctxs-fold-cm797703,The NASDAQ 100 After Hours Indicator is up 2 06 to 5 818 57 The total After hours volume is currently 77 965 143 shares traded The following are the most active stocks for the after hours session J C Penney Company Inc Holding Company JCP is 0 02 at 4 85
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Receives Rare Pediatric Disease Designation for SD-101 for Patients with Epidermolysis Bullosa,2017-05-31 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-receives-rare-pediatric-113000615.html?.tsrc=rss,"Designation Covers Broad Treatment of Epidermolysis Bullosa. Top-Line Phase 3 Data on Track for 3 Q17. CRANBURY, N.J., May 31, 2017-- Amicus Therapeutics, Inc., has received Rare Pediatric Disease designation ..."
FOLD,FOLD:US,BBG000PLF6N0,InPlay from Briefing.com,2017-05-19 11:52:31 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Planned Analysis of Primary Endpoints in Phase 3 Epidermolysis Bullosa Study,2017-05-19 11:30:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-planned-analysis-113000582.html?.tsrc=rss,"CRANBURY, N.J., May 19, 2017-- Amicus Therapeutics, Inc., has completed the analysis plan for the primary endpoints in the blinded ongoing Phase 3 clinical study of the novel topical medicine SD-101 for ..."
FOLD,FOLD:US,BBG000PLF6N0,Today's Research Reports on Biotech Stocks to Watch: Exelixis and Amicus Therapeutics,2017-05-18 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-biotech-stocks-120000509.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 18, 2017 / Despite the recent sell-off triggered by the recent health-care bill that is meant to take the place of the Affordable Care Act, the Biotech Industry has continued ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Positive Functional Data from Initial Patients in Pompe Phase 1/2 Study,2017-05-15 11:00:00 +0000,https://finance.yahoo.com/news/amicus-therapeutics-announces-positive-functional-110000935.html?.tsrc=rss,Mean Six-Minute Walk Distance at Month Six Improved in ERT-Naïve Patients and ERT-Switch Patients. Muscle Function Improved in 9 out of 10 Patients. Pulmonary Function Improved in a Majority of Patients....
FOLD,FOLD:US,BBG000PLF6N0,Edited Transcript of FOLD earnings conference call or presentation 9-May-17 12:30pm GMT,2017-05-10 12:36:03 +0000,http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-182145276.html?.tsrc=rss,Q1 2017 Amicus Therapeutics Inc Earnings Call
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Two Upcoming Investor Conferences,2017-05-10 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-two-upcoming-113000677.html?.tsrc=rss,"CRANBURY, N.J., May 10, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, will present at ..."
FOLD,FOLD:US,BBG000PLF6N0,"ETFs with exposure to Amicus Therapeutics, Inc. : May 9, 2017",2017-05-09 20:37:23 +0000,http://finance.yahoo.com/r/d50f1b0e-256e-3940-ac2b-0ae259793a54/etfs-with-exposure-to-amicus-therapeutics-inc-may-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amicus Therapeutics, Inc. Here are 5 ETFs with the largest exposure to FOLD-US. Comparing the performance and risk of Amicus Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 1Q loss,2017-05-09 12:57:27 +0000,http://finance.yahoo.com/news/amicus-therapeutics-reports-1q-loss-125727729.html?.tsrc=rss,"On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 39 cents. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ..."
FOLD,FOLD:US,BBG000PLF6N0,"Investor Network: Amicus Therapeutics, Inc. to Host Earnings Call",2017-05-09 12:15:00 +0000,http://finance.yahoo.com/news/investor-network-amicus-therapeutics-inc-121500946.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Amicus Therapeutics, Inc. (NASDAQ: FOLD ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 8:30 AM Eastern Time. To ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates,2017-05-09 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-first-quarter-113000383.html?.tsrc=rss,100+ Fabry Disease Patients Now on Reimbursed Galafold in the EU. On Target to Reach 300 Patients on Galafold by Year-End 2017. Additional Important Phase 1/ 2 Pompe Clinical Data Expected in 2 Q17 and ...
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. – Value Analysis (NASDAQ:FOLD) : May 8, 2017",2017-05-08 21:53:05 +0000,http://finance.yahoo.com/r/f42f1075-1993-3f50-957a-6f6a3ec23e16/amicus-therapeutics-inc-value-analysis-nasdaqfold-may-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Amicus Therapeutics, Inc. a score of 13. Our analysis is based on comparing Amicus Therapeutics, Inc. with the following peers – Protalix Biotherapeutics, Inc., Biogen Inc., BioMarin Pharmaceutical Inc., Esperion Therapeutics, Inc., GlaxoSmithKline plc Sponsored ADR, Shire PLC Sponsored ADR, Novo Nordisk A/S Sponsored ADR Class B ... Read more
<b>(Read more...)</b>"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FOLD-US : May 5, 2017",2017-05-05 12:56:51 +0000,http://finance.yahoo.com/r/90bdeac3-1cf2-35d9-be70-f7e7b8870869/amicus-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-fold-us-may-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Amicus Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017",2017-05-02 20:01:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announce-first-quarter-200100631.html?.tsrc=rss,"CRANBURY, N.J., May 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, today announced a conference call and live audio webcast on Tuesday, May ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in France,2017-05-02 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-113000983.html?.tsrc=rss,"CRANBURY, N.J. and PARIS, May 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision medicine ..."
FOLD,FOLD:US,BBG000PLF6N0,InPlay from Briefing.com,2017-04-28 16:55:57 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day,2017-04-06 12:15:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-honors-fabry-disease-121500438.html?.tsrc=rss,"CRANBURY, N.J., April 06, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, is supporting several activities during Fabry Disease Awareness Month ..."
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-04-03 12:01:51 +0000,http://biz.yahoo.com/e/170403/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study,2017-04-03 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-completes-enrollment-essence-113000514.html,"[GlobeNewswire] - Target Exceeded with More than 160 Patients Enrolled. Top-Line Data on Track for 3 Q17. CRANBURY, N.J., April 03, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study,2017-04-03 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-completes-enrollment-essence-113000514.html?.tsrc=rss,"Target Exceeded with More than 160 Patients Enrolled. Top-Line Data on Track for 3 Q17. CRANBURY, N.J., April 03, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies ..."
FOLD,FOLD:US,BBG000PLF6N0,"After Hours Most Active for Mar 20, 2017 :  LYG, BAC, GM, MTG, MPC, HPQ, INTC, AAPL, CSCO, FOLD, MSFT, ARRY",2017-03-20 20:56:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oh9nw22e0l4/after-hours-most-active-for-mar-20-2017-lyg-bac-gm-mtg-mpc-hpq-intc-aapl-csco-fold-msft-arry-cm763155,The NASDAQ 100 After Hours Indicator is down 25 to 5 413 06 The total After hours volume is currently 34 505 353 shares traded The following are the most active stocks for the after hours session Lloyds Banking Group Plc LYG is 0 01 at 3 49 with 10 780 719
FOLD,FOLD:US,BBG000PLF6N0,Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and Sarepta Therapeutics,2017-03-17 13:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-biotech-stocks-133000563.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ..."
FOLD,FOLD:US,BBG000PLF6N0,Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and Sarepta Therapeutics,2017-03-17 13:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-biotech-stocks-133000563.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ..."
FOLD,FOLD:US,BBG000PLF6N0,Are These 2 Biotechs Diamonds in the Rough?,2017-03-16 14:41:00 +0000,https://www.fool.com/investing/2017/03/16/are-these-2-biotechs-diamonds-in-the-rough.aspx,Are These 2 Biotechs Diamonds in the Rough?
FOLD,FOLD:US,BBG000PLF6N0,Are These 2 Biotechs Diamonds in the Rough?,2017-03-16 14:41:00 +0000,http://finance.yahoo.com/r/cd208925-e80f-3f8b-89ac-95dc717bd515/are-these-2-biotechs-diamonds-in-the-rough.aspx?yptr=yahoo&.tsrc=rss,Do Adamas Pharmaceuticals and Amicus Therapeutics have the potential to power your portfolio higher?
FOLD,FOLD:US,BBG000PLF6N0,"Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells ...",2017-03-11 00:11:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EnI2WYygFWA/perceptive-advisors-llc-buys-neurocrine-biosciences-aclaris-therapeutics-galapagos-nv-sells-cm759336,Perceptive Advisors Llc New Purchases GLPG AVDL ACOR IRTC CTMX BCRX ATRS JAZZ ALNY PPHMP Added Positions NBIX ACRS FOLD ANIP AVXS GBT ARDX VBIV ZGNX XNCR Reduced Positions SRPT AERI CRBP ABMD SUPN AGEN BPMC NDRM AGTC
FOLD,FOLD:US,BBG000PLF6N0,4:04 pm Amicus Therapeutics commences the commercial launch of the precision medicine Galafold in Italy following the final publication of reimbursement guidelines by the Ministry of Health,2017-03-08 21:04:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#fold,4:04 pm Amicus Therapeutics commences the commercial launch of the precision medicine Galafold in Italy following the final publication of reimbursement guidelines by the Ministry of Health
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Italy,2017-03-08 21:01:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-210100794.html?.tsrc=rss,"CRANBURY, N.J. and MILAN, Italy, March 08, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Italy,2017-03-08 21:01:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-210100794.html,"[GlobeNewswire] - CRANBURY, N.J. and MILAN, Italy, March 08, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision ..."
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-08 12:47:27 +0000,http://biz.yahoo.com/e/170308/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Harry Boxer’s six biotechnology stocks to watch,2017-03-07 18:55:50 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2,Harry Boxer’s six biotechnology stocks to watch
FOLD,FOLD:US,BBG000PLF6N0,Harry Boxer’s six biotechnology stocks to watch,2017-03-07 18:55:50 +0000,http://finance.yahoo.com/r/c1390f09-319b-30ce-9657-4111d62738db/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"TG Therapeutics, Concert Pharmaceuticals, Kite Pharma and three other companies soared as much as 90%."
FOLD,FOLD:US,BBG000PLF6N0,AMICUS THERAPEUTICS INC Financials,2017-03-07 18:04:14 +0000,http://finance.yahoo.com/q/is?s=fold,AMICUS THERAPEUTICS INC Financials
FOLD,FOLD:US,BBG000PLF6N0,"Four biotech stocks surging on optimism about drug trials, product launches",2017-03-03 14:09:44 +0000,http://finance.yahoo.com/r/6afbc72a-eb16-3e86-a3ee-a58bf2516d97/Story.aspx?guid=9F140324-FF74-11E6-AB63-2E992CB9A6D8&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Harry Boxer highlights bluebird bio, Amicus Therapeutics, Kite Pharma and NeuroDerm."
FOLD,FOLD:US,BBG000PLF6N0,"Four biotech stocks surging on optimism about drug trials, product launches",2017-03-03 14:09:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9F140324-FF74-11E6-AB63-2E992CB9A6D8&siteid=yhoof2,"Four biotech stocks surging on optimism about drug trials, product launches"
FOLD,FOLD:US,BBG000PLF6N0,Biotechs Breaking Out On Drug Development News,2017-03-02 20:34:00 +0000,http://finance.yahoo.com/r/cb14183c-b47f-3fb0-a3a9-6e66ac835dd4/biotechs-breaking-out-on-drug-development-news?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Here are four biotech stocks breaking out on positive developments related to their drugs.
FOLD,FOLD:US,BBG000PLF6N0,Biotechs Breaking Out On Drug Development News,2017-03-02 20:34:00 +0000,http://www.forbes.com/sites/greatspeculations/2017/03/02/biotechs-breaking-out-on-drug-development-news/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Biotechs Breaking Out On Drug Development News
FOLD,FOLD:US,BBG000PLF6N0,4 Biotech Stocks Breaking Out On Positive Drug Developments,2017-03-02 18:47:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwjOnrl12Hc/4-biotech-stocks-breaking-out-on-positive-drug-developments-cm755572,"Here are four biotech stocks breaking out on positive developments related to their drugs.  bluebird bio, Inc. ( BLUE ) has popped about 20 points in a week to Wednesday's close of $92.80.  On Wednesday alone, it rose $5.15 on over 1 million shares traded, closing just a dime off the high. The company announced"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA",2017-03-02 18:15:06 +0000,http://finance.yahoo.com/r/68f16602-4b94-3367-af7d-c94129875cba/amicus-therapeutics-inc-fold-could-be-the-force-that-brings-change-to-the-fda-563277?yptr=yahoo&.tsrc=rss,President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration as burdensome and slow. Trump used the example of the now 20-year-old Megan Crowley who was diagnosed with a rare disease known as Pompe Disease at the age of […]
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA",2017-03-02 18:15:06 +0000,http://www.insidermonkey.com/blog/amicus-therapeutics-inc-fold-could-be-the-force-that-brings-change-to-the-fda-563277/,"Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA"
FOLD,FOLD:US,BBG000PLF6N0,"Dow Soars Above 21,000 for the First Time in History: Today's Reports on Clean Energy Fuels and Amicus Therapeutics",2017-03-02 14:30:00 +0000,http://finance.yahoo.com/news/dow-soars-above-21-000-143000059.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / March 2, 2017 / U.S. markets skyrocketed to record highs Wednesday as President Trump's speech to Congress provided an optimistic view for the U.S. economy and as Federal Reserve ..."
FOLD,FOLD:US,BBG000PLF6N0,"Dow Soars Above 21,000 for the First Time in History: Today's Reports on Clean Energy Fuels and Amicus Therapeutics",2017-03-02 14:30:00 +0000,http://finance.yahoo.com/news/dow-soars-above-21-000-143000059.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 2, 2017 / U.S. markets skyrocketed to record highs Wednesday as President Trump's speech to Congress provided an optimistic view for the U.S. economy and as Federal Reserve ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Upcoming Investor Conferences,2017-03-02 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-upcoming-investor-123000473.html,"[GlobeNewswire] - CRANBURY, N.J., March 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that management will present at two upcoming ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Upcoming Investor Conferences,2017-03-02 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-upcoming-investor-123000473.html?.tsrc=rss,"CRANBURY, N.J., March 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that management will present at two upcoming ..."
FOLD,FOLD:US,BBG000PLF6N0,Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT,2017-03-02 04:22:28 +0000,http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-042228106.html,Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT
FOLD,FOLD:US,BBG000PLF6N0,Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT,2017-03-02 04:22:28 +0000,http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-042228106.html?.tsrc=rss,Q4 2016 Amicus Therapeutics Inc Earnings Call
FOLD,FOLD:US,BBG000PLF6N0,"Pompe drug lauded by Trump costs $300,000 a year",2017-03-01 23:43:34 +0000,http://finance.yahoo.com/news/pompe-drug-lauded-trump-costs-234334222.html,"[Reuters] - President Donald Trump told Congress on Tuesday that more needs to be done to bring down ""artificially high"" prices for prescription drugs, while at the same time praising a drug that turns out to cost $300,000 per year. During the televised address, Trump acknowledged in the audience Megan Crowley, a college student who has Pompe disease - a rare muscle disorder that can be treated with an expensive enzyme replacement therapy. ""But our slow and burdensome approval process at the Food and Drug Administration keeps too many advances, like the one that saved Megan's life, from reaching those in need,"" the president said."
FOLD,FOLD:US,BBG000PLF6N0,"Why Amicus Therapeutics, Inc. Jumped Higher Today",2017-03-01 23:13:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y0cyuxoKu44/why-amicus-therapeutics-inc-jumped-higher-today-cm755094,What happened Amicus Therapeutics NASDAQ FOLD ended the day up 17 after the company s CEO John Crowley and his daughter Megan who has Pompe disease were highlighted during President Donald Trump s address to Congress last night The biotech also announced fourth
FOLD,FOLD:US,BBG000PLF6N0,Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO,2017-03-01 22:51:14 +0000,http://www.cnbc.com/id/104313935?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104313935,Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO
FOLD,FOLD:US,BBG000PLF6N0,Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO,2017-03-01 22:51:14 +0000,http://finance.yahoo.com/news/trumps-latest-comments-constructive-drug-225114019.html?.tsrc=rss,"Amicus Therapeutics CEO Crowley is optimistic about Trump's plans to work with the pharma industry, proposing change for good."
FOLD,FOLD:US,BBG000PLF6N0,"Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM...",2017-03-01 22:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9kCsjH6u6c/gainers--losers-of-mar1-dvax-skln-fold-ipxl-qasm-20170301-01997,"Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics CEO: Trump constructive for our indus...,2017-03-01 21:52:00 +0000,http://finance.yahoo.com/video/amicus-therapeutics-ceo-trump-constructive-215200604.html,Amicus Therapeutics CEO: Trump constructive for our indus...
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics CEO: Trump constructive for our indus...,2017-03-01 21:52:00 +0000,http://finance.yahoo.com/video/amicus-therapeutics-ceo-trump-constructive-215200604.html?.tsrc=rss,"John Crowley, Amicus Therapeutics CEO, discusses the slowdown of the company's Galafold launch, FDA regulation and outlook under President Trump."
FOLD,FOLD:US,BBG000PLF6N0,"Why Amicus Therapeutics, Inc. Jumped Higher Today",2017-03-01 21:50:00 +0000,http://finance.yahoo.com/r/dd530139-c059-3d49-a04c-3d8a8fa99a56/why-amicus-therapeutics-inc-jumped-higher-today.aspx?yptr=yahoo&.tsrc=rss,The biotech could benefit from a softer FDA.
FOLD,FOLD:US,BBG000PLF6N0,"Why Amicus Therapeutics, Inc. Jumped Higher Today",2017-03-01 21:50:00 +0000,http://www.fool.com/investing/2017/03/01/why-amicus-therapeutics-inc-jumped-higher-today.aspx,"Why Amicus Therapeutics, Inc. Jumped Higher Today"
FOLD,FOLD:US,BBG000PLF6N0,Bullish Two Hundred Day Moving Average Cross - FOLD,2017-03-01 18:12:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09HsslhTuWs/bullish-two-hundred-day-moving-average-cross-fold-cm754938,In trading on Wednesday shares of Amicus Therapeutics Inc Symbol FOLD crossed above their 200 day moving average of 6 56 changing hands as high as 7 49 per share Amicus Therapeutics Inc shares are currently trading up about 10 8 on the day The chart below shows the one year performance
FOLD,FOLD:US,BBG000PLF6N0,4 Biopharma Stocks Moving the Market on Wednesday,2017-03-01 16:35:58 +0000,http://finance.yahoo.com/news/4-biopharma-stocks-moving-market-163558646.html,4 Biopharma Stocks Moving the Market on Wednesday
FOLD,FOLD:US,BBG000PLF6N0,4 Biopharma Stocks Moving the Market on Wednesday,2017-03-01 16:35:58 +0000,http://finance.yahoo.com/news/4-biopharma-stocks-moving-market-163558646.html?.tsrc=rss,"These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements."
FOLD,FOLD:US,BBG000PLF6N0,Trump wants to upend the 'slow and burdensome' drug approval process at the FDA — here's what the agency actually does,2017-03-01 15:38:31 +0000,http://finance.yahoo.com/news/trump-wants-upend-slow-burdensome-153831678.html,Trump wants to upend the 'slow and burdensome' drug approval process at the FDA — here's what the agency actually does
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E",2017-03-01 14:16:44 +0000,http://biz.yahoo.com/e/170301/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA",2017-03-01 13:12:00 +0000,http://finance.yahoo.com/r/34404a38-6985-36a5-a855-554b4ed74957/amicus-ceo-john-crowley-not-his-daughter-megan-might-compel-trump-to-make-big-changes-at-fda.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Absent specific policy details, Trump's speech leaves investors guessing about his real plans for the FDA and the drug approval process. He has not yet named an FDA commissioner."
FOLD,FOLD:US,BBG000PLF6N0,"Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA",2017-03-01 13:12:00 +0000,https://www.thestreet.com/story/14021048/1/amicus-ceo-john-crowley-not-his-daughter-megan-might-compel-trump-to-make-big-changes-at-fda.html?puc=yahoo&cm_ven=YAHOO,"Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA"
FOLD,FOLD:US,BBG000PLF6N0,Q4 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open,2017-03-01 12:07:03 +0000,http://biz.yahoo.com/research/earncal/20170301.html?t=fold,Q4 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates,2017-03-01 12:00:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-full-2016-120000170.html?.tsrc=rss,Growing Momentum for EU Galafold Launch for Fabry Disease Tracking Toward 300 Patients by Year-End 2017. Target Enrollment Achieved in Phase 1/ 2 Pompe Study– Additional Data Expected in 2 Q17 and 3 Q17. ...
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates,2017-03-01 12:00:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-full-2016-120000170.html,[GlobeNewswire] - Growing Momentum for EU Galafold Launch for Fabry Disease Tracking Toward 300 Patients by Year-End 2017. Target Enrollment Achieved in Phase 1/ 2 Pompe Study– Additional Data Expected in 2 Q17 and 3 Q17. ...
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold in UK,2017-02-28 14:55:00 +0000,http://finance.yahoo.com/r/ef9c2d3b-cdc3-3ee3-9cd4-f6f0914c159a/amicus-therapeutics-launches-galafold-uk-fold?partner=YahooSA&yptr=yahoo&.tsrc=rss,Amicus rolled out its Fabry disease drug Galafold in the UK.
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold in UK,2017-02-28 14:55:00 +0000,http://www.investopedia.com/news/amicus-therapeutics-launches-galafold-uk-fold/?partner=YahooSA,Amicus Therapeutics Launches Galafold in UK
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in the United Kingdom,2017-02-27 13:00:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-130000116.html,"[GlobeNewswire] - National Institute for Health and Care Excellence Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease. CRANBURY, N.J., Feb. 27, 2017-- Amicus Therapeutics, a global biotechnology ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in the United Kingdom,2017-02-27 13:00:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-130000116.html?.tsrc=rss,"National Institute for Health and Care Excellence Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease. CRANBURY, N.J., Feb. 27, 2017-- Amicus Therapeutics, a global biotechnology ..."
FOLD,FOLD:US,BBG000PLF6N0,Could 2017 Prove to be a Bull Market for Biotechs? Today's Reports on Depomed and Amicus Therapeutics,2017-02-23 14:30:00 +0000,http://finance.yahoo.com/news/could-2017-prove-bull-market-143000749.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Biotech Industry has posted some impressive gains since election result and the rally has continued for the larger part of this year. Both the iShares ..."
FOLD,FOLD:US,BBG000PLF6N0,These Small Biotechs Are Poised to Go Higher,2017-02-23 11:00:00 +0000,http://www.investopedia.com/news/these-small-biotechs-are-poised-go-higher-gbt-vsar/?partner=YahooSA,These Small Biotechs Are Poised to Go Higher
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce Full-Year 2016 Financial Results and Corporate Updates on March 1, 2017",2017-02-22 22:36:53 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announce-full-2016-223653907.html,"[GlobeNewswire] - CRANBURY, N.J., Feb. 22, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call and live audio webcast ..."
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-02-16 12:17:42 +0000,http://biz.yahoo.com/e/170216/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Presents Additional Positive Preliminary Phase 1/2 Data at WORLDSymposium™ 2017,2017-02-16 00:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-presents-additional-positive-003000920.html,[GlobeNewswire] - Biomarkers of Muscle Damage Demonstrate Improving Trends in Majority of Patients. Biomarker of Key Disease Substrate Demonstrates Improving Trend in All Patients. Safety Data Continue to Show No Infusion-Associated ...
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Updates Migalastat Drug,2017-02-15 17:49:00 +0000,http://www.investopedia.com/news/amicus-posts-positive-update-migalastat-fold/?partner=YahooSA,Amicus Therapeutics Updates Migalastat Drug
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-02-15 13:42:16 +0000,http://biz.yahoo.com/e/170215/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Presents Important New Scientific Findings and Preclinical Data for Pompe Program at WORLDSymposium™ 2017,2017-02-15 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-presents-important-scientific-123000767.html,[GlobeNewswire] - Scientific Findings Reveal that Cellular Damage Alters Trafficking for Key Proteins Involved in Muscle Membrane Integrity and Muscle Repair. Preclinical Studies Demonstrate Reversal of Cellular Damage ...
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Highlights New Fabry Program Data at WORLDSymposium™ 2017,2017-02-15 00:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-highlights-fabry-program-003000100.html,[GlobeNewswire] - New Phase 3 Retrospective Analysis Shows Correlation between Reduction in Disease Substrate and Improved Diarrhea in Fabry Patients with Amenable Mutations treated with Migalastat. Supportive Study for ...
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers",2017-02-09 21:03:24 +0000,http://biz.yahoo.com/e/170209/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare Conference,2017-02-06 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-leerink-partners-123000888.html,"[GlobeNewswire] - CRANBURY, N.J., Feb. 06, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, ..."
FOLD,FOLD:US,BBG000PLF6N0,"Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo",2017-01-24 14:26:00 +0000,https://www.thestreet.com/story/13963644/1/biotech-premarket-movers-amicus-therapeutics-nantkwest-and-organovo.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Presentations and Posters at 13th Annual WORLDSymposium™ 2017,2017-01-24 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-presentations-posters-123000112.html,"[GlobeNewswire] - CRANBURY, N.J., Jan. 24, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that 3 oral presentations and 9 posters highlighting ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics upgraded by Robert W. Baird,2017-01-24 11:48:44 +0000,http://finance.yahoo.com/q/ud?s=FOLD,Amicus Therapeutics upgraded by Robert W. Baird
FOLD,FOLD:US,BBG000PLF6N0,"Tuesday Sector Laggards: Drugs, Biotechnology Stocks",2017-01-17 19:36:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S14gvhTV0Bk/tuesday-sector-laggards-drugs-biotechnology-stocks-cm734384,In trading on Tuesday drugs shares were relative laggards down on the day by about 2 4 Helping drag down the group were shares of Alcobra ADHD off about 49 9 and shares of Concert Pharmaceuticals CNCE off about 13 7 on the day Also lagging the market Tuesday
FOLD,FOLD:US,BBG000PLF6N0,Mid-Day Market Update: Clayton Williams Energy Surges On Acquisition News; Christopher & Banks Shares Slide,2017-01-17 18:47:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v-jMGE0xX0c/mid-day-market-update-clayton-williams-energy-surges-on-acquisition-news-christopher-banks-shares-slide-cm734389,Midway through trading Tuesday the Dow traded down 0 27 percent to 19 831 39 while the NASDAQ declined 0 54 percent to 5 543 93 The S amp P also fell dropping 0 29 percent to 2 268 01 Leading and Lagging Sectors Non cyclical consumer goods amp services shares gained around 1
FOLD,FOLD:US,BBG000PLF6N0,"Friday's ETF Movers: XBI, GDXJ",2017-01-13 19:37:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMOI-mdCAYA/fridays-etf-movers-xbi-gdxj-cm733435,In trading on Friday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 9 on the day Components of that ETF showing particular strength include shares of Amicus Therapeutics FOLD up about 9 8 and shares of Array Biopharma ARRY up about 8 8 on the
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Provides Full-Year 2017 Strategic Outlook and Financial Guidance,2017-01-09 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-provides-full-2017-123000960.html,[GlobeNewswire] - Strong Momentum for Galafold Launch in Europe and Multiple Global Regulatory Submissions Ahead. Additional Data from Pompe Phase 1/ 2 Clinical Study and Top-Line Data from Phase 3 Epidermolysis Bullosa ...
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,",2017-01-09 12:08:13 +0000,http://biz.yahoo.com/e/170109/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,"
FOLD,FOLD:US,BBG000PLF6N0,"Huge Energy Trade Kicks Off 2017 Insider Buying: DCP Midstream, Och-Ziff Capital, TransEnterix, Amicus Therapeutics and More",2017-01-08 15:10:56 +0000,http://finance.yahoo.com/news/huge-energy-trade-kicks-off-151056231.html,"Huge Energy Trade Kicks Off 2017 Insider Buying: DCP Midstream, Och-Ziff Capital, TransEnterix, Amicus Therapeutics and More"
FOLD,FOLD:US,BBG000PLF6N0,"After Hours Most Active for Jan 4, 2017 :  CC, IDXX, ABT, MT, STJ, BAC, MSFT, PK, QQQ, EBAY, FOLD, INTC",2017-01-04 21:56:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6NMzbGf3s5o/after-hours-most-active-for-jan-4-2017-cc-idxx-abt-mt-stj-bac-msft-pk-qqq-ebay-fold-intc-cm729571,The NASDAQ 100 After Hours Indicator is down 1 61 to 4 935 6 The total After hours volume is currently 36 360 338 shares traded The following are the most active stocks for the after hours session Chemours Company The CC is 0 06 at 22 15 with 17 634 647
FOLD,FOLD:US,BBG000PLF6N0,National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafold™ (migalastat) for Fabry Disease in England,2017-01-04 13:33:19 +0000,http://www.publicnow.com/view/C26868CFA78CE5F5BEFD716D2E1A4E11E37248F7,"[at noodls] - January 4, 2017 Reimbursement Secured for Patients in England Commercial Launch in England, Wales and Northern Ireland Anticipated in Early 2017 CRANBURY, N.J., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Amicus ..."
FOLD,FOLD:US,BBG000PLF6N0,National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafold™ (migalastat) for Fabry Disease in England,2017-01-04 12:30:00 +0000,http://finance.yahoo.com/news/national-institute-health-care-excellence-123000377.html,"[GlobeNewswire] - Reimbursement Secured for Patients in England. Commercial Launch in England, Wales and Northern Ireland Anticipated in Early 2017. CRANBURY, N.J., Jan. 04, 2017-- Amicus Therapeutics, a global biotechnology ..."
FOLD,FOLD:US,BBG000PLF6N0,5 Stocks Insiders Love Right Now,2017-01-01 17:40:00 +0000,https://www.thestreet.com/story/13938062/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO,5 Stocks Insiders Love Right Now
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib",2016-12-30 21:20:19 +0000,http://biz.yahoo.com/e/161230/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib"
FOLD,FOLD:US,BBG000PLF6N0,"Trump, Interest Rates And Biotech Investing In 2017",2016-12-23 16:22:00 +0000,http://www.forbes.com/sites/stephenbrozak/2016/12/23/trump-interest-rates-and-biotech-investing-in-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Trump, Interest Rates And Biotech Investing In 2017"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference,2016-12-23 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-35th-annual-123000817.html,"[GlobeNewswire] - CRANBURY, N.J., Dec. 23, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief ..."
FOLD,FOLD:US,BBG000PLF6N0,"Abercrombie, OvaScience Slide Into Thursday’s 52-Week Low Club",2016-12-22 21:04:17 +0000,http://247wallst.com/investing/2016/12/22/369341/,"Abercrombie, OvaScience Slide Into Thursday’s 52-Week Low Club"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. (FOLD) Announces The Closure Of Its Senior Convertible Notes",2016-12-22 19:02:55 +0000,http://www.insidermonkey.com/blog/amicus-therapeutics-inc-fold-announces-the-closure-of-its-senior-convertible-notes-512813/,"Amicus Therapeutics, Inc. (FOLD) Announces The Closure Of Its Senior Convertible Notes"
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def",2016-12-21 22:28:58 +0000,http://biz.yahoo.com/e/161221/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Closing of Offering of Senior Convertible Notes and Exercise in Full of Option to Purchase Additional Notes,2016-12-21 22:12:06 +0000,http://www.publicnow.com/view/2C224BE221209335F334F9A87858A37D11D0921E,"[at noodls] - December 21, 2016 CRANBURY, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, announced the closing ..."
FOLD,FOLD:US,BBG000PLF6N0,Today's Reports on Biotech Movers Ariad Pharmaceuticals and Amicus Therapeutics,2016-12-21 14:15:00 +0000,http://finance.yahoo.com/news/todays-reports-biotech-movers-ariad-141500749.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 21, 2016 / After many years of impressive gains for investors the Biotech Industry has experienced downward pressure in 2016. The iShares NASDAQ Biotechnology Index ..."
FOLD,FOLD:US,BBG000PLF6N0,"Abercrombie & Fitch, Hanesbrands Dip into Friday’s 52-Week Low Club",2016-12-16 21:04:24 +0000,http://247wallst.com/investing/2016/12/16/abercrombie-fitch-hanesbrands-dip-into-fridays-52-week-low-club/,"Abercrombie & Fitch, Hanesbrands Dip into Friday’s 52-Week Low Club"
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-16 11:03:32 +0000,http://biz.yahoo.com/e/161216/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Pricing of Offering of Convertible Senior Notes,2016-12-16 01:58:18 +0000,http://www.publicnow.com/view/22AC6891BE78CC0155889A04AD09C711F0F5DA1E,"[at noodls] - December 15, 2016 CRANBURY, N.J., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that ..."
FOLD,FOLD:US,BBG000PLF6N0,"Health Care Sector Update for 12/15/2016: FOLD,CBIO,PFE,PACB",2016-12-15 19:36:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U1O1ArTpQD4/health-care-sector-update-for-12152016-foldcbiopfepacb-cm722138,Top Health Care StocksTop Health Care Stocks Health care stocks were moderately higher in early afternoon trade with the NYSE Health Care Index rising about 0 4 while shares of health care companies in the S amp P 500 were up about 0 4 as a group Health care stocks were moderately higher
FOLD,FOLD:US,BBG000PLF6N0,Mid-Day Market Update: Pier 1 Imports Surges On Strong Results; PacBio Shares Slide,2016-12-15 18:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LhqxLLxx1cs/mid-day-market-update-pier-1-imports-surges-on-strong-results-pacbio-shares-slide-cm722096,Midway through trading Thursday the Dow traded up 0 70 percent to 19 930 17 while the NASDAQ rose 0 77 percent to 5 478 77 The S amp P also rose gaining 0 66 percent to 2 268 20 Leading and Lagging Sectors Financial shares gained around 0 90 percent in trading on
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. (FOLD): Breaking Down The Raise",2016-12-15 16:51:21 +0000,http://www.insidermonkey.com/blog/amicus-therapeutics-inc-fold-breaking-down-the-raise-510586/,"Amicus Therapeutics, Inc. (FOLD): Breaking Down The Raise"
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Stock Is Sinking Today,2016-12-15 15:00:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E-R2X9LltII/why-amicus-therapeutics-stock-is-sinking-today-cm721790,Image source Getty Images What happened Shares of the rare disease drugmaker Amicus Therapeutics NASDAQ FOLD fell by more than 11 in pre market trading today after the company announced a 225 million convertible 160 senior note offering So what Amicus move
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Stock Is Sinking Today,2016-12-15 13:42:15 +0000,http://www.fool.com/investing/2016/12/15/why-amicus-therapeutics-stock-is-sinking-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Amicus Therapeutics Stock Is Sinking Today
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-14 22:12:00 +0000,http://biz.yahoo.com/e/161214/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Proposed Offering of Convertible Senior Notes,2016-12-14 21:01:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-proposed-offering-210100746.html,"[GlobeNewswire] - CRANBURY, N.J., Dec. 14, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, announced today that it intends to offer $225,000,000 aggregate principal ..."
FOLD,FOLD:US,BBG000PLF6N0,"ETFs with exposure to Amicus Therapeutics, Inc. : December 14, 2016",2016-12-14 16:44:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-amicus-therapeutics-inc-december-14-2016/,"ETFs with exposure to Amicus Therapeutics, Inc. : December 14, 2016"
FOLD,FOLD:US,BBG000PLF6N0,Hedge Funds Are Betting On James River Group Holdings Ltd (JRVR),2016-12-12 22:00:07 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-betting-on-james-river-group-holdings-ltd-jrvr-503805/,Hedge Funds Are Betting On James River Group Holdings Ltd (JRVR)
FOLD,FOLD:US,BBG000PLF6N0,Is Amicus Therapeutics a Bad-News Buy?,2016-12-09 16:59:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cu7R_NHPxls/is-amicus-therapeutics-a-bad-news-buy-cm719341,Amicus Therapeutics NASDAQ FOLD 160 recently reported that the FDA will require an additional study before it will agree to review an application to approve its Fabry disease drug Galafold Because investors had hoped that Galafold which is already available in Europe could
FOLD,FOLD:US,BBG000PLF6N0,Is Amicus Therapeutics a Bad-News Buy?,2016-12-09 15:03:42 +0000,http://www.fool.com/investing/2016/12/09/is-amicus-therapeutics-a-bad-news-buy.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Amicus Therapeutics a Bad-News Buy?
FOLD,FOLD:US,BBG000PLF6N0,"FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data",2016-12-09 01:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0x3bVdhiw8/fold-slowly-unfolding-ebs-continues-contract-spree-hznp-plunges-on-trial-data-20161209-00013,"FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data"
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-08 13:36:50 +0000,http://biz.yahoo.com/e/161208/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease,2016-12-08 12:00:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-positive-preliminary-120000914.html,[GlobeNewswire] - ATB200/AT2221 Safety Data Show No Infusion-Associated Reactions Following 100+ Infusions. Clinical Pharmacokinetic Profile as Predicted Based on Previously Reported Preclinical Data. Biomarkers of Muscle ...
FOLD,FOLD:US,BBG000PLF6N0,"Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy?",2016-12-07 07:10:12 +0000,http://www.insidermonkey.com/blog/is-amicus-therapeutics-inc-fold-a-good-stock-to-buy-500305/,"Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy?"
FOLD,FOLD:US,BBG000PLF6N0,The Latest Buzz in Biotech,2016-12-06 21:26:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EpVsy00YKRg/the-latest-buzz-in-biotech-cm717591,In this week s episode of Industry Focus Healthcare Motley Fool analyst Michael Douglass and Fool contributor Todd Campbell go over three of the biggest recent stories in healthcare Shares in Juno Therapeutics NASDAQ JUNO and 160 Amicus Therapeutics
FOLD,FOLD:US,BBG000PLF6N0,The Latest Buzz in Biotech,2016-12-06 21:19:34 +0000,http://www.fool.com/investing/2016/12/06/the-latest-buzz-in-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Latest Buzz in Biotech
FOLD,FOLD:US,BBG000PLF6N0,6 Companies That Destroyed Shareholders Last Week,2016-12-03 14:25:33 +0000,http://247wallst.com/investing/2016/12/03/6-companies-that-destroyed-shareholders-last-week-7/,6 Companies That Destroyed Shareholders Last Week
FOLD,FOLD:US,BBG000PLF6N0,"SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Amicus Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-01 19:28:00 +0000,http://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-192800082.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Amicus Therapeutics, Inc. concerning possible violations of federal securities laws."
FOLD,FOLD:US,BBG000PLF6N0,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD",2016-12-01 16:42:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-164200044.html,"[PR Newswire] - NEW YORK, Dec. 1, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amicus Therapeutics, Inc. (""Amicus"" or the ""Company"") (FOLD). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. On this news, Amicus stock fell $1.81, or 21.75%, to close at $6.51 on November 29, 2016. The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation."
FOLD,FOLD:US,BBG000PLF6N0,"ETFs with exposure to Amicus Therapeutics, Inc. : December 1, 2016",2016-12-01 16:03:13 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-amicus-therapeutics-inc-december-1-2016/,"ETFs with exposure to Amicus Therapeutics, Inc. : December 1, 2016"
FOLD,FOLD:US,BBG000PLF6N0,"Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno",2016-11-30 14:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/atDqxlHRKLw/biotech-stock-roundup-actelion-soars-on-acquisition-talks-another-clinical-hold-for-juno-cm715582,Switzerland based Actelion ALIOF confirmed that it is in preliminary talks with Johnson amp Johnson which is looking to acquire the company that is focused on the discovery development and commercialization of drugs for diseases with significant unmet medical needs Meanwhile Juno JUNO
FOLD,FOLD:US,BBG000PLF6N0,Amicus Fabry Disease Drug Delayed to 2020 (FOLD),2016-11-30 14:40:00 +0000,http://www.investopedia.com/news/amicus-tanks-fabry-disease-drug-delayed-fold/?partner=YahooSA,Amicus Fabry Disease Drug Delayed to 2020 (FOLD)
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FOLD-US : November 30, 2016",2016-11-30 12:35:53 +0000,http://www.capitalcube.com/blog/index.php/amicus-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-fold-us-november-30-2016/,"Amicus Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FOLD-US : November 30, 2016"
FOLD,FOLD:US,BBG000PLF6N0,"Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno",2016-11-30 12:13:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-actelion-soars-121312797.html,"Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Provides Regulatory Update on Fabry Disease Drug,2016-11-29 23:54:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XyyY2mIXl-k/amicus-provides-regulatory-update-on-fabry-disease-drug-cm715417,Amicus Therapeutics Inc FOLD issued an update on the regulatory pathway for migalastat for the treatment of Fabry disease in the U S Subsequent to several collaborative discussions with the FDA including the receipt of final written minutes from an in person type B meeting the company
FOLD,FOLD:US,BBG000PLF6N0,What Happened in the Stock Market Today,2016-11-29 22:54:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-RBN2jrt2YY/what-happened-in-the-stock-market-today-cm715377,Image source Getty Images A late afternoon slump wasn t enough to keep stocks from posting gains on Tuesday The Dow Jones Industrial Average DJINDICES DJI and the S amp P 500 SNPINDEX GSPC indexes each finished higher by about 0 1 Today s stock
FOLD,FOLD:US,BBG000PLF6N0,Amicus Provides Regulatory Update on Fabry Disease Drug,2016-11-29 22:06:10 +0000,http://finance.yahoo.com/news/amicus-provides-regulatory-fabry-disease-220610865.html,Amicus Provides Regulatory Update on Fabry Disease Drug
FOLD,FOLD:US,BBG000PLF6N0,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc. (FOLD)",2016-11-29 21:44:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-214400534.html,"[PR Newswire] - NEW YORK, Nov. 29, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Amicus Therapeutics, Inc. ..."
FOLD,FOLD:US,BBG000PLF6N0,"Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD)",2016-11-29 21:14:13 +0000,http://www.insidermonkey.com/blog/biotech-movers-and-shakers-nivalis-therapeutics-inc-nvls-and-amicus-therapeutics-inc-fold-494978/,"Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD)"
FOLD,FOLD:US,BBG000PLF6N0,FDA Requests Additional Data on Amicus’ Fabry Disease Treatment,2016-11-29 20:44:33 +0000,http://finance.yahoo.com/news/fda-requests-additional-data-amicus-204433198.html,FDA Requests Additional Data on Amicus’ Fabry Disease Treatment
FOLD,FOLD:US,BBG000PLF6N0,Mid-Afternoon Market Update: Crude Oil Down 3.5%; Thor Industries Shares Surge On Earnings Beat,2016-11-29 20:43:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pJRdQ05tqrA/mid-afternoon-market-update-crude-oil-down-35-thor-industries-shares-surge-on-earnings-beat-cm715338,Toward the end of trading Tuesday the Dow traded up 0 21 percent to 19 137 87 while the NASDAQ climbed 0 59 percent to 5 400 69 The S amp P also rose gaining 0 35 percent to 2 209 49 Leading and Lagging Sectors Tuesday afternoon healthcare shares gained by 0 61
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Shares Are Crashing 21.8% Today,2016-11-29 19:54:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCMh-saDq2U/why-amicus-therapeutics-shares-are-crashing-218-today-cm715294,Image source Getty Images What happened After announcing that a new trial will be necessary before it can file for FDA approval of its Fabry disease drug shares of Amicus Therapeutics NASDAQ FOLD 160 are tumbling 21 8 at 12 00 p m EST Tuesday So what
FOLD,FOLD:US,BBG000PLF6N0,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Amicus Therapeutics, Inc.",2016-11-29 18:35:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-183500432.html,"[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Amicus Therapeutics, Inc. concerning possible violations of federal securities laws by certain officers and directors."
FOLD,FOLD:US,BBG000PLF6N0,Mid-Day Market Update: U.S. Stocks Turn Higher; Nivalis Therapeutics Shares Tumble After Failed Drug Trial,2016-11-29 18:17:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5CzkObvrE_4/mid-day-market-update-us-stocks-turn-higher-nivalis-therapeutics-shares-tumble-after-failed-drug-trial-cm715265,Midway through trading Tuesday the Dow traded up 0 15 percent to 19 126 46 while the NASDAQ climbed 0 62 percent to 5 401 98 The S amp P also rose gaining 0 32 percent to 2 208 67 Leading and Lagging Sectors On Tuesday healthcare shares gained by 0 58 percent Meanwhile
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Shares Are Crashing 21.8% Today,2016-11-29 18:11:59 +0000,http://www.fool.com/investing/general/2016/11/29/why-amicus-therapeutics-shares-are-crashing-218-to.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Amicus Therapeutics Shares Are Crashing 21.8% Today
FOLD,FOLD:US,BBG000PLF6N0,Mid-Morning Market Update: Markets Edge Lower; Tiffany Tops Q3 Expectations,2016-11-29 16:17:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t4syQRUpja0/mid-morning-market-update-markets-edge-lower-tiffany-tops-q3-expectations-cm715169,Following the market opening Tuesday the Dow traded down 0 11 percent to 19 076 23 while the NASDAQ declined 0 13 percent to 5 362 05 The S amp P also fell dropping 0 14 percent to 2 198 71 Leading and Lagging Sectors Tuesday morning non cyclical consumer goods amp
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Nov 29, 2016 :  MT, VALE, ASML, BAC, PBR, CHK, FCX, FOLD, NVLS, ARIA, AAPL, VBLT",2016-11-29 13:53:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jsqjv-V8SsQ/pre-market-most-active-for-nov-29-2016-mt-vale-asml-bac-pbr-chk-fcx-fold-nvls-aria-aapl-vblt-cm714920,The NASDAQ 100 Pre Market Indicator is up 4 29 to 4 861 31 The total Pre Market volume is currently 7 175 241 shares traded The following are the most active stocks for the pre market session ArcelorMittal MT is 0 08 at 7 48 with 1 115 952 shares traded MT s
FOLD,FOLD:US,BBG000PLF6N0,Futures Flat as Investors Take Profits; Asia Mixed,2016-11-29 02:52:00 +0000,https://www.thestreet.com/story/13906803/1/futures-flat-as-investors-take-profits-asia-mixed.html?puc=yahoo&cm_ven=YAHOO,Futures Flat as Investors Take Profits; Asia Mixed
FOLD,FOLD:US,BBG000PLF6N0,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX",2016-11-29 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_blUfWqs7IM/fold-shrinks-jazz-on-right-track-nvls-choked-up-aaap-on-watch-nvro-sues-bsx-20161129-00005,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Says FDA Didn't Grant Accelerated Approval For Migalastat; Stock Plunges,2016-11-28 22:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hYbmatdFiEo/amicus-says-fda-didnt-grant-accelerated-approval-for-migalastat-stock-plunges-20161128-00995,Amicus Says FDA Didn't Grant Accelerated Approval For Migalastat; Stock Plunges
FOLD,FOLD:US,BBG000PLF6N0,Amicus shares drop 28% after FDA denies quick drug approval,2016-11-28 22:25:58 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=E41D7876-3E6A-4CB2-9CBE-6BB4A4D87B6C&siteid=yhoof2,Amicus shares drop 28% after FDA denies quick drug approval
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits",2016-11-28 21:48:05 +0000,http://biz.yahoo.com/e/161128/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan,2016-11-28 21:34:00 +0000,https://www.thestreet.com/story/13906602/1/amicus-tumbles-on-lengthy-delay-to-u-s-fabry-drug-fda-filing-plan.html?puc=yahoo&cm_ven=YAHOO,Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces U.S. Regulatory Pathway for Migalastat for Fabry Disease,2016-11-28 21:10:05 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-u-regulatory-211005898.html,[GlobeNewswire] - Regulatory Plan for Full Approval Pathway Based on Generation of Additional Gastrointestinal Symptoms Data. Intermediate Expanded Access Program Expected to Begin in 2017. Conference Call Today at 4:30pm ...
FOLD,FOLD:US,BBG000PLF6N0,"Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?",2016-11-15 17:27:29 +0000,http://www.insidermonkey.com/blog/is-redmile-group-right-to-bet-on-array-biopharma-inc-arry-amicus-therapeutics-inc-fold-two-other-stocks-487363/,"Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?"
FOLD,FOLD:US,BBG000PLF6N0,Journal of Medical Genetics Publishes Pivotal Phase 3 ATTRACT Study of Migalastat for Patients with Fabry Disease,2016-11-11 12:30:00 +0000,http://finance.yahoo.com/news/journal-medical-genetics-publishes-pivotal-123000653.html,"[GlobeNewswire] - CRANBURY, N.J., Nov. 11, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 012 evaluating ..."
FOLD,FOLD:US,BBG000PLF6N0,"ETF’s with exposure to Amicus Therapeutics, Inc. : November 9, 2016",2016-11-09 17:48:02 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-amicus-therapeutics-inc-november-9-2016/,"ETF’s with exposure to Amicus Therapeutics, Inc. : November 9, 2016"
FOLD,FOLD:US,BBG000PLF6N0,"Biotech Gainers On Tuesday: Amicus Therapeutics, Inc. (FOLD) And Ionis Pharmaceuticals Inc (IONS)",2016-11-08 21:51:30 +0000,http://www.insidermonkey.com/blog/biotech-gainers-on-tuesday-amicus-therapeutics-inc-fold-and-ionis-pharmaceuticals-inc-ions-485902/,"Biotech Gainers On Tuesday: Amicus Therapeutics, Inc. (FOLD) And Ionis Pharmaceuticals Inc (IONS)"
FOLD,FOLD:US,BBG000PLF6N0,Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed,2016-11-08 17:53:44 +0000,http://www.insidermonkey.com/blog/big-bet-on-sarepta-therapeutics-inc-srpt-lifts-perceptive-advisors-q3-returns-see-how-other-investments-performed-485488/,Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
FOLD,FOLD:US,BBG000PLF6N0,Amicus 3Q Loss $47M or 32 Cents a Share (FOLD),2016-11-08 14:30:00 +0000,http://www.investopedia.com/news/amicus-stock-spikes-21-despite-3q-loss-fold/?partner=YahooSA,Amicus 3Q Loss $47M or 32 Cents a Share (FOLD)
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : FOLD-US : November 8, 2016",2016-11-08 12:54:33 +0000,http://www.capitalcube.com/blog/index.php/amicus-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-fold-us-november-8-2016/,"Amicus Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : FOLD-US : November 8, 2016"
FOLD,FOLD:US,BBG000PLF6N0,"Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss",2016-11-07 21:54:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ShvSTl-mBNI/heres-why-amicus-therapeutics-inc-soared-as-much-as-20-despite-an-earnings-miss-cm705248,Image source Getty Images What happened Shares of Amicus Therapeutics NASDAQ FOLD a biopharmaceutical company focused on the development of therapies primarily designed to treat ultra rare and rare diseases surged as much as 20 during Monday s trading session
FOLD,FOLD:US,BBG000PLF6N0,Edited Transcript of FOLD earnings conference call or presentation 7-Nov-16 1:30pm GMT,2016-11-07 21:43:48 +0000,http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-214348974.html,Edited Transcript of FOLD earnings conference call or presentation 7-Nov-16 1:30pm GMT
FOLD,FOLD:US,BBG000PLF6N0,"Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss",2016-11-07 20:22:50 +0000,http://www.fool.com/investing/2016/11/07/heres-why-amicus-therapeutics-inc-soared-as-much-a.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss"
FOLD,FOLD:US,BBG000PLF6N0,"Health Care Sector Update for 11/07/2016: FOLD,IONS,CXRX",2016-11-07 19:34:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Awqyhe657Xk/health-care-sector-update-for-11072016-foldionscxrx-cm705212,Top Health Care StocksTop Health Care Stocks JNJ 1 29 JNJ 1 29 PFE 1 05 PFE 1 05 MRK 1 64 MRK 1 64 ABT 1 87 ABT 1 87 AMGN 3 17 AMGN 3 17 Health care stocks were extending their strong gains again this afternoon with the NYSE Health Care Index increasing 1 8 while shares of
FOLD,FOLD:US,BBG000PLF6N0,FOLD Makes Bullish Cross Above Critical Moving Average,2016-11-07 18:03:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fcpFz0UJ-Yc/fold-makes-bullish-cross-above-critical-moving-average-cm705046,In trading on Monday shares of Amicus Therapeutics Inc Symbol FOLD crossed above their 200 day moving average of 6 92 changing hands as high as 7 04 per share Amicus Therapeutics Inc shares are currently trading up about 14 5 on the day The chart below shows the one year performance
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E",2016-11-07 13:40:31 +0000,http://biz.yahoo.com/e/161107/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 3Q loss,2016-11-07 13:04:51 +0000,http://sg.finance.yahoo.com/news/amicus-therapeutics-reports-3q-loss-130451347.html,Amicus Therapeutics reports 3Q loss
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Third Quarter 2016 Financial Results and Corporate Updates,2016-11-07 12:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-third-quarter-123000752.html,"[GlobeNewswire] - Strong Momentum for Galafold Launch in Europe and Further Global Regulatory Submissions. Initial Data from Pompe Phase 1/ 2 Clinical Study on Track for 4 Q16. CRANBURY, N.J., Nov. 07, 2016-- Amicus Therapeutics, ..."
FOLD,FOLD:US,BBG000PLF6N0,Q3 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open,2016-11-07 12:07:07 +0000,http://biz.yahoo.com/research/earncal/20161107.html?t=fold,Q3 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce Third Quarter 2016 Financial Results on November 7, 2016",2016-11-01 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announce-third-quarter-113000712.html,"[GlobeNewswire] - CRANBURY, N.J., Nov. 01, 2016-- Amicus Therapeutics, a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Monday, ..."
FOLD,FOLD:US,BBG000PLF6N0,Genetic Stocks to Watch for Earnings on Nov 1: GILD & More,2016-10-31 14:16:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a8RySugHg7M/genetic-stocks-to-watch-for-earnings-on-nov-1-gild-more-cm700965,As Q3 earnings season gains momentum approximately 291 S amp P 500 members representing 58 2 of the index s total market capitalization have already reported quarterly results as of Oct 28 While total earnings for these 291 index members were up 2 2 year over year revenues inched
FOLD,FOLD:US,BBG000PLF6N0,Genetic Stocks to Watch for Earnings on Nov 1: GILD & More,2016-10-31 13:21:01 +0000,http://finance.yahoo.com/news/genetic-stocks-watch-earnings-nov-132101449.html,Genetic Stocks to Watch for Earnings on Nov 1: GILD & More
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Financial Statements and Exhibits",2016-10-28 20:26:51 +0000,http://biz.yahoo.com/e/161028/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Five Cheap Healthcare Stocks Poised to Explode,2016-10-08 13:22:00 +0000,http://www.insidermonkey.com/blog/five-cheap-healthcare-stocks-poised-to-explode-2-477599/,Five Cheap Healthcare Stocks Poised to Explode
FOLD,FOLD:US,BBG000PLF6N0,Mid-Morning Market Update: Markets Open Lower; Janus Capital And Henderson Group Announce All-Stock Merger,2016-10-03 15:27:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qyhhb6gkGi8/mid-morning-market-update-markets-open-lower-janus-capital-and-henderson-group-announce-all-stock-merger-cm687814,Following the market opening Monday the Dow traded down 0 31 percent to 18 251 83 while the NASDAQ declined 0 33 percent to 5 294 57 The S amp P also fell dropping 0 31 percent to 2 161 59 Leading and Lagging Sectors Monday morning cyclical consumer goods amp services
FOLD,FOLD:US,BBG000PLF6N0,3 Biotechs With Potential Big-Time Upside,2016-09-27 11:42:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jBmDC4FzuN4/3-biotechs-with-potential-big-time-upside-cm684877,Image source Getty Images Investors who succeed in the small cap biotech market have learned to temper their expectations Only a small number of these companies succeed and the constant chance 160 of a big drop is 160 tough on the stomach lining But for those who have a
FOLD,FOLD:US,BBG000PLF6N0,3 Biotechs With Potential Big-Time Upside,2016-09-26 20:28:00 +0000,http://www.fool.com/investing/2016/09/26/3-biotechs-with-potential-big-time-upside.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs With Potential Big-Time Upside
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at LEERINK Roundtable Series: Rare Disease & Immuno-Oncology,2016-09-22 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-leerink-roundtable-113000278.html,"[GlobeNewswire] - CRANBURY, N.J., Sept. 22, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief ..."
FOLD,FOLD:US,BBG000PLF6N0,"Commit To Buy Amicus Therapeutics At $5, Earn 15% Using Options",2016-09-20 17:22:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F1P1b4dTADc/commit-to-buy-amicus-therapeutics-at-5-earn-15-using-options-cm682140,Investors considering a purchase of Amicus Therapeutics Inc Symbol FOLD stock but cautious about paying the going market price of 8 09 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
FOLD,FOLD:US,BBG000PLF6N0,Bullish Two Hundred Day Moving Average Cross - FOLD,2016-09-16 22:17:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QuXEoHSLRm0/bullish-two-hundred-day-moving-average-cross-fold-cm680777,In trading on Friday shares of Amicus Therapeutics Inc Symbol FOLD crossed above their 200 day moving average of 7 21 changing hands as high as 7 32 per share Amicus Therapeutics Inc shares are currently trading up about 3 on the day The chart below shows the one year performance of
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-14 10:05:24 +0000,http://biz.yahoo.com/e/160914/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics, Inc. :FOLD-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016",2016-09-13 19:17:39 +0000,http://www.capitalcube.com/blog/index.php/amicus-therapeutics-inc-fold-us-earnings-analysis-q2-2016-by-the-numbers-september-13-2016/,"Amicus Therapeutics, Inc. :FOLD-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016"
FOLD,FOLD:US,BBG000PLF6N0,UPDATE -- Amicus Therapeutics to Present at Bank of America Merrill Lynch Global Healthcare Conference 2016,2016-09-13 15:51:57 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-bank-america-155157980.html,"[GlobeNewswire] - CRANBURY, N.J., Sept. 13, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Bank of America Merrill Lynch Global Healthcare Conference 2016,2016-09-12 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-bank-america-113000680.html,"[GlobeNewswire] - CRANBURY, N.J., Sept. 12, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, ..."
FOLD,FOLD:US,BBG000PLF6N0,Implied IHE Analyst Target Price: $188,2016-09-09 13:31:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Txsp7xyINkA/implied-ihe-analyst-target-price-188-cm676697,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-07 12:20:22 +0000,http://biz.yahoo.com/e/160907/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Robert W. Baird & Co. 2016 Healthcare Conference,2016-09-01 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-present-robert-w-113000652.html,"[GlobeNewswire] - CRANBURY, N.J., Sept. 01, 2016-- Amicus Therapeutics, a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, will ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Highlight Fabry Disease Program at Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium,2016-08-31 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-highlight-fabry-disease-113000913.html,"[GlobeNewswire] - CRANBURY, N.J., Aug. 31, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, today announced that 7 posters highlighting its Fabry program will be included ..."
FOLD,FOLD:US,BBG000PLF6N0,Mid-Morning Market Update: Markets Open Higher; USG To Divest L&W Supply For $670M,2016-08-29 15:31:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LekDlV4myM4/mid-morning-market-update-markets-open-higher-usg-to-divest-lw-supply-for-670m-cm671737,"Following the market opening Monday, the Dow traded up 0.40 percent to 18,468.71 while the NASDAQ climbed 0.25 percent to 5,232.08. The S&P also rose, gaining 0.38 percent to 2,177.27.  Leading and Lagging Sectors"
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Financial Statements and Exhibits",2016-08-23 20:11:46 +0000,http://biz.yahoo.com/e/160823/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Biotech Industry on the Upswing after Rocky Start to 2016,2016-08-17 13:29:05 +0000,http://news.investornetwork.com/2016/08/17/biotech-industry-on-the-upswing-after-rocky-start-to-2016/?1=1&1471440545,Biotech Industry on the Upswing after Rocky Start to 2016
FOLD,FOLD:US,BBG000PLF6N0,Amicus (FOLD) CEO Crowley to CNBC: 'Our Job is to Stay Focused and Keep Making Great Medicines',2016-08-11 13:30:00 +0000,https://www.thestreet.com/story/13672540/1/amicus-fold-ceo-crowley-to-cnbc-our-job-is-to-stay-focused-and-keep-making-great-medicines.html?puc=yahoo&cm_ven=YAHOO,Amicus (FOLD) CEO Crowley to CNBC: 'Our Job is to Stay Focused and Keep Making Great Medicines'
FOLD,FOLD:US,BBG000PLF6N0,Rare disease drug innovation: Amicus CEO,2016-08-11 10:41:00 +0000,http://finance.yahoo.com/video/rare-disease-drug-innovation-amicus-104100467.html,Rare disease drug innovation: Amicus CEO
FOLD,FOLD:US,BBG000PLF6N0,UPDATE -- New England Journal of Medicine Publishes Pivotal Phase 3 FACETS Study of Migalastat for Patients with Fabry Disease,2016-08-10 22:05:55 +0000,http://finance.yahoo.com/news/england-journal-medicine-publishes-pivotal-220555729.html,"[GlobeNewswire] - CRANBURY, N.J., Aug. 10, 2016-- Amicus Therapeutics, a biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 011 evaluating the efficacy ..."
FOLD,FOLD:US,BBG000PLF6N0,New England Journal of Medicine Publishes Pivotal Phase 3 FACETS Study of Migalastat for Patients with Fabry Disease,2016-08-10 21:18:45 +0000,http://finance.yahoo.com/news/england-journal-medicine-publishes-pivotal-211845422.html,"[GlobeNewswire] - CRANBURY, N.J., Aug. 10, 2016-- Amicus Therapeutics, a biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 011 evaluating the efficacy ..."
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-08-10 21:02:15 +0000,http://biz.yahoo.com/e/160810/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
FOLD,FOLD:US,BBG000PLF6N0,Edited Transcript of FOLD earnings conference call or presentation 9-Aug-16 12:30pm GMT,2016-08-09 19:44:34 +0000,http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-194434529.html,Edited Transcript of FOLD earnings conference call or presentation 9-Aug-16 12:30pm GMT
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics (FOLD) Stock Slumps on Q2 Loss,2016-08-09 14:59:00 +0000,https://www.thestreet.com/story/13669670/1/amicus-therapeutics-fold-stock-slumps-on-q2-loss.html?puc=yahoo&cm_ven=YAHOO,Amicus Therapeutics (FOLD) Stock Slumps on Q2 Loss
FOLD,FOLD:US,BBG000PLF6N0,Health Care Sector Update for 08/09/2016: FOLD,2016-08-09 12:31:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fEuni8u8MyU/health-care-sector-update-for-08092016-fold-cm662260,"Top Health care stocks JNJ flat PFE +0.2% ABT flat MRK flat AMGN flat Health care shares were mainly unchanged in pre market trade on Tuesday. In health care stocks news, Amicus Therapeutics ( FOLD ) reported a wider"
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E",2016-08-09 11:58:52 +0000,http://biz.yahoo.com/e/160809/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce Second Quarter 2016 Financial Results on August 9, 2016",2016-08-09 11:50:02 +0000,http://www.publicnow.com/view/00F8C331CABE61B2BDFC728A293B4DF06FE91DEB,"[at noodls] - CRANBURY, N.J., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 2Q loss,2016-08-09 11:41:27 +0000,http://sg.finance.yahoo.com/news/amicus-therapeutics-reports-2q-loss-114127344.html,Amicus Therapeutics reports 2Q loss
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Second Quarter 2016 Financial Results and Corporate Updates,2016-08-09 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-announces-second-quarter-113000830.html,[GlobeNewswire] - Significant Progress with EU Galafold Launch and Regulatory Submissions. Enrollment in Pompe Phase 1/ 2 Clinical Study on Track with Initial Data Expected in 2 H16. Elevation of“ Time to Wound Closure” ...
FOLD,FOLD:US,BBG000PLF6N0,Q2 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open,2016-08-09 11:07:01 +0000,http://biz.yahoo.com/research/earncal/20160809.html?t=fold,Q2 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Submit Japanese New Drug Application for Migalastat for Fabry Disease in 1H17,2016-08-03 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-submit-japanese-drug-113000430.html,"[GlobeNewswire] - Pre-Submission Meeting Completed with Pharmaceuticals and Medical Devices Agency in Japan. PMDA Confirms That No Further Clinical Studies Are Needed for Submission. CRANBURY, N.J., Aug. 03, 2016-- Amicus ..."
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib",2016-07-29 20:14:07 +0000,http://biz.yahoo.com/e/160729/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib"
FOLD,FOLD:US,BBG000PLF6N0,"Wednesday Sector Leaders: Biotechnology, Precious Metals",2016-07-27 19:22:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OvZkNN-AU80/wednesday-sector-leaders-biotechnology-precious-metals-cm655895,"In trading on Wednesday, biotechnology shares were relative leaders, up on the day by about 2.3%. Leading the group were shares of Sequenom ( SQNM ), up about 178% and shares of Amicus Therapeutics ( FOLD ) up about"
FOLD,FOLD:US,BBG000PLF6N0,"Wednesday's ETF Movers: XBI, FXN",2016-07-27 19:22:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mBCG0UGnHCI/wednesdays-etf-movers-xbi-fxn-cm655881,"In trading on Wednesday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 1.7% on the day. Components of that ETF showing particular strength include shares of Amicus Therapeutics ( FOLD ), up about"
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics Appoints Former FDA Division Deputy Director Andrew Mulberg as Vice President, Regulatory Strategy",2016-07-12 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-appoints-former-fda-113000580.html,"[GlobeNewswire] - Former Deputy Director of FDA Division of Gastroenterology and Inborn Errors Products. Brings Significant Drug Development and Pharmaceutical Industry Experience. CRANBURY, N.J., July 12, 2016-- Amicus ..."
FOLD,FOLD:US,BBG000PLF6N0,"Chinese Economy Stable in Second Quarter, Premier Li Keqiang Says",2016-07-12 07:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X2y8ehBDTsg/chinese-economy-stable-in-second-quarter-premier-li-keqiang-says-20160712-00291,"Chinese Economy Stable in Second Quarter, Premier Li Keqiang Says"
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or",2016-07-06 20:07:38 +0000,http://biz.yahoo.com/e/160706/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Expands Biologics Pipeline with New Preclinical Program for Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency,2016-07-06 20:01:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-expands-biologics-pipeline-200100353.html,"[GlobeNewswire] - CRANBURY, N.J., July 06, 2016-- Amicus Therapeutics, Inc., a biotechnology company at the forefront of rare and orphan diseases, has expanded its biologics pipeline with a new preclinical program for cyclin-dependent ..."
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia",2016-07-01 10:05:45 +0000,http://biz.yahoo.com/e/160701/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia"
FOLD,FOLD:US,BBG000PLF6N0,Research Report Initiated on Select Biotechnology Equities,2016-06-24 12:54:25 +0000,http://news.investornetwork.com/2016/06/24/research-report-initiated-on-select-biotechnology-equities/?1=1&1466772865,Research Report Initiated on Select Biotechnology Equities
FOLD,FOLD:US,BBG000PLF6N0,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot",2016-06-13 18:25:14 +0000,http://biz.yahoo.com/e/160613/fold8-k.html,"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot"
FOLD,FOLD:US,BBG000PLF6N0,"Health Care Sector Update for 06/10/2016: RPTP, FOLD",2016-06-10 13:28:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bI4wM-AXbfc/health-care-sector-update-for-06102016-rptp-fold-cm633416,"Top Health care stocks JNJ 0.7% PFE 0.5% ABT flat MRK 0.5% AMGN flat Health care shares were mainly lower in pre market trade on Friday. In health care stocks news, Raptor Pharmaceutical ( RPTP ), a biopharmaceutical developer"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Appoints Craig A. Wheeler to Board of Directors,2016-06-10 11:30:00 +0000,http://finance.yahoo.com/news/amicus-therapeutics-appoints-craig-wheeler-113000722.html,"[GlobeNewswire] - CRANBURY, N.J., June 10, 2016-- Amicus Therapeutics, a biotechnology company at the forefront of rare and orphan diseases, today announced the election and appointment of Craig A. Wheeler to its Board ..."
FOLD,FOLD:US,BBG000PLF6N0,"Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors",2016-06-09 12:19:11 +0000,http://www.publicnow.com/view/3841C451D784713FDC9EE64F8EF5EDBFD5D8E2B1,"[at noodls] - June 9, 2016 TARRYTOWN, N.Y., June 09, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating ..."
FOLD,FOLD:US,BBG000PLF6N0,Mid-Afternoon Market Update: U.S. Stocks Turn Positive; American Woodmark Shares Fall On Earnings Miss,2016-06-02 20:07:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H0dabOccqO4/mid-afternoon-market-update-us-stocks-turn-positive-american-woodmark-shares-fall-on-earnings-miss-cm629814,"Toward the end of trading Thursday, the Dow traded up 0.18 percent to 17,821.51 while the NASDAQ climbed 0.21 percent to 4,962.80. The S&P also rose, gaining 0.16 percent to 2,102.65.  Leading and Lagging Sectors"
FOLD,FOLD:US,BBG000PLF6N0,Amicus' Fabry disease drug gets European Commission approval,2016-05-31 12:18:08 +0000,http://sg.finance.yahoo.com/news/amicus-fabry-disease-drug-gets-121808665.html,Amicus' Fabry disease drug gets European Commission approval
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 1Q loss,2016-05-03 12:01:03 +0000,http://sg.finance.yahoo.com/news/amicus-therapeutics-reports-1q-loss-120103800.html,Amicus Therapeutics reports 1Q loss
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce First Quarter 2016 Financial Results on May 3, 2016",2016-05-03 11:20:12 +0000,http://www.publicnow.com/view/31E29230F65DE0B4AAC5EA1C66AC2DCB0460ECCC,"[at noodls] - CRANBURY, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of rare and orphan diseases, today announced a conference call and live audio ..."
FOLD,FOLD:US,BBG000PLF6N0,Ligand (LGND) Q1 Earnings: What's in Store for the Stock?,2016-05-02 17:51:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HxD0l0Qmk0I/ligand-lgnd-q1-earnings-whats-in-store-for-the-stock-cm614778,"Ligand Pharmaceuticals IncorporatedLGND is scheduled to report first quarter 2016 results on May 4 before the market opens. In the last reported quarter, Ligand had posted a positive earnings surprise of 1.96%. Let's see how things are shaping up"
FOLD,FOLD:US,BBG000PLF6N0,Merck (MRK) Q1 Earnings: Can the Stock Pull a Surprise?,2016-05-02 17:51:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lsGx50vIGHY/merck-mrk-q1-earnings-can-the-stock-pull-a-surprise-cm614774,"Merck & Co. Inc.MRK is scheduled to report its first quarter 2016 earnings results on May 5, before the opening bell. Last quarter, Merck had posted a positive earnings surprise of 2.20%. Let's see how things are shaping up"
FOLD,FOLD:US,BBG000PLF6N0,What Caused Amicus Therapeutics Shares To Skyrocket 23% Last Month,2016-04-12 22:00:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0QfymS1bx_g/what-caused-amicus-therapeutics-shares-to-skyrocket-23-last-month-cm605454,"SOURCE  AMICUS THERAPEUTICS  What   After reporting additional late stage trial data and ahead of learning that a key European advisory committee had voted in support of its lead drug, shares"
FOLD,FOLD:US,BBG000PLF6N0,"Pre-Market Most Active for Apr 12, 2016 :  SRC, AA, E, HQY, CHK, TVIX, BHP, QQQ, JNPR, QAT, FOLD, SBUX",2016-04-12 12:59:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O6rdDvZDuR4/pre-market-most-active-for-apr-12-2016-src-aa-e-hqy-chk-tvix-bhp-qqq-jnpr-qat-fold-sbux-cm604872,"The NASDAQ 100 Pre Market Indicator is up 2.46 to 4,461.17. The total Pre Market volume is currently 16,562,372 shares traded. The following are the most active stocks for the pre market session Spirit Realty Capital, Inc. ( SRC"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Closes In on a 9-Figure Opportunity,2016-04-02 02:24:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KlruoaZqeSw/amicus-therapeutics-closes-in-on-a-9-figure-opportunity-cm600853,"SOURCE  FLICKR USER STOCKMONKEYS.COM.  Following news that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is recommending EU approval for Amicus Therapeutics ' lead product candidate, shares"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Receives Positive CHMP Opinion for Approval of Migalastat in Patients with Fabry Disease in European Union,2016-04-01 16:03:09 +0000,http://www.publicnow.com/view/7BBAE6BD2B526B2031B9A462DC4144EB9ABB8D36,"[at noodls] - Broad Label for All Fabry Patients with an Amenable Genetic Mutation Conference Call Today at 12:30 pm ET CRANBURY, N.J., April 01, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Expanded Access Program for Migalastat,2016-03-22 11:40:25 +0000,http://www.publicnow.com/view/3E3B235F50C7AF4FB21D91D3F14B8814C26566FD,"[at noodls] - CRANBURY, N.J., March 22, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, has initiated a reimbursed expanded ..."
FOLD,FOLD:US,BBG000PLF6N0,3 Emerging Biotech Stocks I'm Watching Like a Hawk,2016-03-19 17:10:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sVjSuBwlwgI/3-emerging-biotech-stocks-im-watching-like-a-hawk-cm595405,"SOURCE  FLICKR USER STOCKMONKEYS.COM.  Needle moving news could soon hit for three small cap biotech stocks. If investors aren't paying attention, they could miss out on an opportunity. Specifically, the FDA"
FOLD,FOLD:US,BBG000PLF6N0,Mid-Day Market Update: Stage Stores Drops On Earnings Miss; Tumi Holdings Shares Jump,2016-03-03 18:26:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sYh77nKnlDA/mid-day-market-update-stage-stores-drops-on-earnings-miss-tumi-holdings-shares-jump-cm587979,"Midway through trading Thursday, the Dow traded down 0.45 percent to 16,823.61 while the NASDAQ declined 0.60 percent to 4,675.39. The S&P also fell, dropping 0.45 percent to 1,977.60.  Leading and Lagging Sectors  On Thursday,"
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Shares Are Skyrocketing Again Today,2016-03-02 20:38:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YLZuMzwUvKc/why-amicus-therapeutics-shares-are-skyrocketing-again-today-cm587462,"SOURCE  AMICUS THERAPEUTICS.  What  Following an 11.2% rally due to the release of new phase 3 data yesterday, shares in Amicus Therapeutics climbed by another 12.05% at 1 45 p.m."
FOLD,FOLD:US,BBG000PLF6N0,Why Amicus Therapeutics Shares Are Up Today,2016-03-01 23:20:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DysFfhIwz2g/why-amicus-therapeutics-shares-are-up-today-cm586947,"IMAGE SOURCE  AMICUS THERAPEUTICS.  What  After Amicus Therapeutics reported new phase 3 data for its lead product candidate, its stock jumped higher by 10% at 3 00 p.m. ET today."
FOLD,FOLD:US,BBG000PLF6N0,3 Underappreciated Healthcare Stocks I Still Love,2016-02-14 13:50:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VE7wySFH1aI/3-underappreciated-healthcare-stocks-i-still-love-cm579687,"Source  Flickr user Gene Tobia.  Love is in the air, so it's the perfect time to discuss why I still adore these three lesser known companies even though their shares have taken"
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Provides Full-Year 2016 Strategic Outlook and Financial Guidance,2016-01-11 13:08:04 +0000,http://www.noodls.com/view/906BF042DD2AB777FFA93E151E7143C270495515,"[at noodls] - Migalastat for Fabry Disease Moving Toward CHMP Opinion in Pompe Disease Clinical Study Initiated to Investigate Novel Enzyme Replacement Therapy Epidermolysis Bullosa (EB) Phase 3 Study Advances , (GLOBE ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference and 3rd Annual Dermatology Summit,2016-01-04 21:30:18 +0000,http://www.noodls.com/view/944F2F4E7CC5AE0542909F7DFA3F84162E1D8D57,"[at noodls] - , (GLOBE NEWSWIRE) -- (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that the Company will present at two conferences in during the week of - 16, ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Commences Phase 1/2 Study of Novel ERT for Treatment of Pompe Disease,2015-12-22 12:50:23 +0000,http://www.noodls.com/view/B2430E6DD58080133F3844FBA6A50A7DAED86DF1,"[at noodls] - IND Open and Clinical Sites Being Initiated First Amicus Proprietary Biologic to , (GLOBE NEWSWIRE) -- (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at Goldman Sachs US Emerging / SMID Cap Growth Conference,2015-11-12 21:06:11 +0000,http://www.noodls.com/view/FBC0D586325E7393B5C06574D6118B140263F049,"[at noodls] - CRANBURY, N.J., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that Chip Baird, Chief Financial ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Announces Third Quarter 2015 Financial Results and Corporate Updates,2015-11-03 21:17:05 +0000,http://www.noodls.com/view/876B1E6E278F69E6DB963F3C22423E340956D9E6,[at noodls] - Migalastat for Fabry Disease Moving Forward to CHMP Opinion in European Union Novel Pompe ERT Advancing to Enter Phase 1/2 Study in Pompe Patients Rolling NDA Now Initiated for SD-101 for Epidermolysis ...
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 3Q loss,2015-11-03 21:08:24 +0000,http://sg.finance.yahoo.com/news/amicus-therapeutics-reports-3q-loss-210824164.html,Amicus Therapeutics reports 3Q loss
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Announce Third Quarter 2015 Financial Results on November 3, 2015",2015-10-27 20:17:08 +0000,http://www.noodls.com/view/531CF8B1DDCDEEDACA91096BE4C74C8F9EC5287C,"[at noodls] - CRANBURY, N.J., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Tuesday, November 3, 2015 at 4:30 p.m. ET to discuss financial ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Host FDA Update Conference Call Today,2015-10-02 14:50:01 +0000,http://www.noodls.com/view/23F61BB1E187ABD8824F3D09633CAE155B4AEC1D,[at noodls] - Amicus Therapeutics to Host FDA Update Conference Call Today
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics Completes Acquisition of Scioderm, Inc.",2015-09-30 12:08:03 +0000,http://www.noodls.com/view/05350269AEE5DE5DD3232E0F879D90BC6E399D8D,"[at noodls] - Amicus Therapeutics Completes Acquisition of Scioderm, Inc."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics to Present at LEERINK Partners Rare Disease Roundtable,2015-09-22 11:45:03 +0000,http://www.noodls.com/view/7808438FA2385DBC714BB2640422B955CBDCD8EC,"[at noodls] - CRANBURY, N.J., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of rare and orphan diseases, today announced that John F. Crowley, Chairman ..."
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics Plans to Submit New Drug Application (NDA) for Migalastat for Fabry Disease Following Positive Pre-NDA Meeting With FDA,2015-09-15 11:27:04 +0000,http://www.noodls.com/view/C2AF229740E030F3BC648497DA88A977A66FFE2C,"[at noodls] - NDA Submission to Request Accelerated Approval (Subpart H) on Track for 4Q15 CRANBURY, N.J., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront ..."
FOLD,FOLD:US,BBG000PLF6N0,"Amicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc.",2015-08-31 10:13:10 +0000,http://www.noodls.com/view/F1E66E8112DF4A035ED584F5FA435FB59ACB1DDE,[at noodls] - Scioderm's Lead Drug Candidate Zorblisa™ in Phase 3 Study for Rare Disease Epidermolysis Bullosa (EB) Granted FDA Breakthrough Therapy Designation FDA Has Agreed to Rolling NDA Submission for Zorblisa ...
FOLD,FOLD:US,BBG000PLF6N0,Amicus to seek Fabry disease drug approval,2015-03-19 16:46:28 +0000,http://sg.finance.yahoo.com/news/amicus-seek-fabry-disease-drug-164628782.html,Amicus to seek Fabry disease drug approval
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics reports 4Q loss,2015-03-03 21:42:46 +0000,http://sg.finance.yahoo.com/news/amicus-therapeutics-reports-4q-loss-214246484.html,Amicus Therapeutics reports 4Q loss
FOLD,FOLD:US,BBG000PLF6N0,Amicus Therapeutics posts 3Q loss,2014-11-06 23:30:54 +0000,http://sg.finance.yahoo.com/news/amicus-therapeutics-posts-3q-loss-233054064--finance.html,Amicus Therapeutics posts 3Q loss
